"ES"	"p_val"	"path"	"hits"	"hits_n"
"Glutathione metabolism"	-Inf	1	"Glutathione metabolism"	""	0
"Alanine and aspartate metabolism"	-Inf	1	"Alanine and aspartate metabolism"	""	0
"Translation factors"	-Inf	1	"Translation factors"	""	0
"Electron transport chain OXPHOS system in mitochondria"	-Inf	0.40735116966817	"Electron transport chain OXPHOS system in mitochondria"	""	0
"GPCRs other"	-Inf	0.642803694312354	"GPCRs other"	""	0
"Osteoclast signaling"	-Inf	1	"Osteoclast signaling"	""	0
"IL 5 signaling pathway"	-Inf	1	"IL 5 signaling pathway"	""	0
"Matrix metalloproteinases"	-Inf	1	"Matrix metalloproteinases"	""	0
"Pentose phosphate metabolism"	-Inf	1	"Pentose phosphate metabolism"	""	0
"Phase I biotransformations non P450"	-Inf	1	"Phase I biotransformations non P450"	""	0
"Androgen receptor signaling pathway"	-0.37808999833924	1	"Androgen receptor signaling pathway"	"10401"	1
"AMP activated protein kinase signaling"	-Inf	1	"AMP activated protein kinase signaling"	""	0
"Sphingolipid pathway"	-Inf	1	"Sphingolipid pathway"	""	0
"Ganglio sphingolipid metabolism"	-Inf	1	"Ganglio sphingolipid metabolism"	""	0
"Bone morphogenic protein signaling and regulation"	-Inf	1	"Bone morphogenic protein signaling and regulation"	""	0
"Fatty acid beta oxidation"	-Inf	1	"Fatty acid beta oxidation"	""	0
"Nucleotide binding oligomerization domain NOD pathway"	0.78791995309969	0.439898117640045	"Nucleotide binding oligomerization domain NOD pathway"	"3551"	1
"Osteopontin signaling"	1.82354386283041	0.167632895222882	"Osteopontin signaling"	"3551"	1
"Influenza A virus infection"	-Inf	1	"Influenza A virus infection"	""	0
"Serotonin transporter activity"	-Inf	1	"Serotonin transporter activity"	""	0
"Target of rapamycin signaling"	-Inf	1	"Target of rapamycin signaling"	""	0
"Glycine metabolism"	-Inf	1	"Glycine metabolism"	""	0
"Selenium micronutrient network"	-Inf	0.636273867508579	"Selenium micronutrient network"	""	0
"Physiological and pathological hypertrophy of the heart"	1.44503223957668	0.287486720546743	"Physiological and pathological hypertrophy of the heart"	"5600"	1
"miRNA regulation of DNA damage response"	-Inf	0.628109680753719	"miRNA regulation of DNA damage response"	""	0
"Vitamin D metabolism"	-Inf	1	"Vitamin D metabolism"	""	0
"Vitamin B12 metabolism"	-Inf	1	"Vitamin B12 metabolism"	""	0
"Angiogenesis"	-Inf	1	"Angiogenesis"	""	0
"Energy metabolism"	0.860069738855525	0.14507467691664	"Energy metabolism"	"3276;23082"	2
"MicroRNAs in cardiomyocyte hypertrophy"	-1.57562723098941	1	"MicroRNAs in cardiomyocyte hypertrophy"	"3551"	1
"miRNAs involved in DNA damage response"	-Inf	1	"miRNAs involved in DNA damage response"	""	0
"Transcription factors regulate miRNAs related to cardiac hypertrophy"	-Inf	1	"Transcription factors regulate miRNAs related to cardiac hypertrophy"	""	0
"Type II diabetes mellitus"	1.56050945699662	0.256609871505098	"Type II diabetes mellitus"	"3551"	1
"Folate alcohol and cancer pathway hypotheses"	-Inf	1	"Folate alcohol and cancer pathway hypotheses"	""	0
"Heart development"	-Inf	1	"Heart development"	""	0
"Nicotine metabolism in liver cells"	-Inf	1	"Nicotine metabolism in liver cells"	""	0
"Fluoropyrimidine activity"	-Inf	1	"Fluoropyrimidine activity"	""	0
"Nicotine effect on dopaminergic neurons"	-Inf	1	"Nicotine effect on dopaminergic neurons"	""	0
"Nicotine effect on chromaffin cells"	-Inf	1	"Nicotine effect on chromaffin cells"	""	0
"Codeine and morphine metabolism"	-Inf	1	"Codeine and morphine metabolism"	""	0
"Eicosanoid synthesis"	-Inf	1	"Eicosanoid synthesis"	""	0
"Nuclear receptors"	-Inf	1	"Nuclear receptors"	""	0
"TP53 network"	-Inf	1	"TP53 network"	""	0
"Folate metabolism"	-Inf	1	"Folate metabolism"	""	0
"Apoptosis modulation and signaling"	-0.595995028683374	1	"Apoptosis modulation and signaling"	"3551"	1
"Cell cycle"	-1.2032561965133	1	"Cell cycle"	"29882"	1
"Proteasome degradation"	-Inf	0.999999999999999	"Proteasome degradation"	""	0
"Integrin mediated cell adhesion"	-0.554967760423319	1	"Integrin mediated cell adhesion"	"8874"	1
"Homologous recombination"	-Inf	1	"Homologous recombination"	""	0
"Peroxisomal beta oxidation of tetracosanoyl CoA"	-Inf	1	"Peroxisomal beta oxidation of tetracosanoyl CoA"	""	0
"Cori cycle"	-Inf	1	"Cori cycle"	""	0
"IL 1 signaling pathway"	0.0369475009396044	0.534207439252969	"IL 1 signaling pathway"	"3551"	1
"Cholesterol biosynthesis pathway"	-Inf	1	"Cholesterol biosynthesis pathway"	""	0
"Integrated cancer pathway"	-Inf	1	"Integrated cancer pathway"	""	0
"Thyroxine thyroid hormone production"	1.44503223957668	0.29749369331376	"Thyroxine thyroid hormone production"	"65010"	1
"Sterol regulatory element binding proteins SREBP signaling"	-Inf	1	"Sterol regulatory element binding proteins SREBP signaling"	""	0
"SRF and miRs in smooth muscle differentiation and proliferation"	-Inf	1	"SRF and miRs in smooth muscle differentiation and proliferation"	""	0
"Genes targeted by miRNAs in adipocytes"	-Inf	1	"Genes targeted by miRNAs in adipocytes"	""	0
"Effects of nitric oxide"	-Inf	1	"Effects of nitric oxide"	""	0
"Iron metabolism in placenta"	1.3905844555543	0.143786337822337	"Iron metabolism in placenta"	"48"	1
"SREBF and miR33 in cholesterol and lipid homeostasis"	-Inf	1	"SREBF and miR33 in cholesterol and lipid homeostasis"	""	0
"RANKL RANK signaling pathway"	1.23858136210925	0.154820412638127	"RANKL RANK signaling pathway"	"7186;3551"	2
"Cell differentiation expanded index"	-Inf	1	"Cell differentiation expanded index"	""	0
"Cell differentiation index"	-Inf	1	"Cell differentiation index"	""	0
"Thyroid stimulating hormone TSH signaling pathway"	-Inf	1	"Thyroid stimulating hormone TSH signaling pathway"	""	0
"Leptin signaling pathway"	-0.37808999833924	1	"Leptin signaling pathway"	"3551"	1
"Follicle stimulating hormone FSH signaling pathway"	-Inf	1	"Follicle stimulating hormone FSH signaling pathway"	""	0
"TNF related weak inducer of apoptosis TWEAK signaling pathway"	1.47304661574628	0.0987354235664744	"TNF related weak inducer of apoptosis TWEAK signaling pathway"	"7186;3551"	2
"Prolactin signaling pathway"	0.653618861388099	0.277739254742576	"Prolactin signaling pathway"	"10401;7409"	2
"Microtubule cytoskeleton regulation"	-Inf	1	"Microtubule cytoskeleton regulation"	""	0
"IL 7 signaling pathway"	-Inf	1	"IL 7 signaling pathway"	""	0
"Alzheimer 39 s disease and miRNA effects"	-1.10245555572581	0.591779121033044	"Alzheimer 39 s disease and miRNA effects"	"7186;3551"	2
"Fatty acid omega oxidation"	-Inf	1	"Fatty acid omega oxidation"	""	0
"Neural crest differentiation"	-0.797042547621467	1	"Neural crest differentiation"	"7020"	1
"IL 17 signaling pathway"	0.860069738855525	0.36374585694788	"IL 17 signaling pathway"	"3551"	1
"Type III interferon signaling"	-Inf	1	"Type III interferon signaling"	""	0
"Arrhythmogenic right ventricular cardiomyopathy"	-Inf	0.6285505828186	"Arrhythmogenic right ventricular cardiomyopathy"	""	0
"Endothelin pathways"	-Inf	1	"Endothelin pathways"	""	0
"IL 9 signaling pathway"	-Inf	1	"IL 9 signaling pathway"	""	0
"Thymic stromal lymphopoietin TSLP signaling pathway"	-Inf	1	"Thymic stromal lymphopoietin TSLP signaling pathway"	""	0
"Metastatic brain tumor"	-Inf	1	"Metastatic brain tumor"	""	0
"Pilocytic astrocytoma"	-Inf	1	"Pilocytic astrocytoma"	""	0
"Glioblastoma signaling pathways"	-Inf	0.632089995064986	"Glioblastoma signaling pathways"	""	0
"Androgen receptor network in prostate cancer"	-Inf	0.409015225598931	"Androgen receptor network in prostate cancer"	""	0
"Synaptic vesicle pathway"	-Inf	1	"Synaptic vesicle pathway"	""	0
"Pathogenic Escherichia coli infection"	-Inf	1	"Pathogenic Escherichia coli infection"	""	0
"Glial cell differentiation"	-Inf	1	"Glial cell differentiation"	""	0
"Drug induction of bile acid pathway"	-Inf	1	"Drug induction of bile acid pathway"	""	0
"Irinotecan pathway"	-Inf	1	"Irinotecan pathway"	""	0
"RalA downstream regulated genes"	-Inf	1	"RalA downstream regulated genes"	""	0
"Deregulation of Rab and Rab effector genes in bladder cancer"	-Inf	1	"Deregulation of Rab and Rab effector genes in bladder cancer"	""	0
"B cell receptor signaling pathway"	0.338117035660169	0.370334906483679	"B cell receptor signaling pathway"	"7409;3551"	2
"TNF alpha signaling pathway"	0.390584455554305	0.355149348002739	"TNF alpha signaling pathway"	"7186;3551"	2
"AGE RAGE pathway"	-0.102455555725812	0.607203728434635	"AGE RAGE pathway"	"3551"	1
"Allograft rejection"	-Inf	0.639350404519374	"Allograft rejection"	""	0
"Interleukin 11 signaling pathway"	1.41755150315457	0.126011817460116	"Interleukin 11 signaling pathway"	"10401;3551"	2
"Trans sulfuration pathway"	-Inf	1	"Trans sulfuration pathway"	""	0
"miRNA biogenesis"	-Inf	1	"miRNA biogenesis"	""	0
"Corticotropin releasing hormone signaling pathway"	-0.887951043819677	1	"Corticotropin releasing hormone signaling pathway"	"7020"	1
"Parkin ubiquitin proteasomal system pathway"	-Inf	0.627950240702368	"Parkin ubiquitin proteasomal system pathway"	""	0
"Adipogenesis"	-Inf	0.266834446651841	"Adipogenesis"	""	0
"Gastric cancer network 1"	-Inf	1	"Gastric cancer network 1"	""	0
"Gastric cancer network 2"	-Inf	1	"Gastric cancer network 2"	""	0
"Butyrate induced histone acetylation"	-Inf	1	"Butyrate induced histone acetylation"	""	0
"Histone modifications"	-Inf	1	"Histone modifications"	""	0
"Parkinson 39 s disease pathway"	0.78791995309969	0.415575850732174	"Parkinson 39 s disease pathway"	"5600"	1
"Oncostatin M signaling pathway"	-0.0639814079111763	0.547245915320777	"Oncostatin M signaling pathway"	"10401"	1
"Brain derived neurotrophic factor BDNF signaling pathway"	-1.12131458297713	1	"Brain derived neurotrophic factor BDNF signaling pathway"	"3551"	1
"Peptide GPCRs"	-Inf	0.628109680753719	"Peptide GPCRs"	""	0
"Cardiac progenitor differentiation"	-Inf	1	"Cardiac progenitor differentiation"	""	0
"One carbon metabolism"	-Inf	1	"One carbon metabolism"	""	0
"Spinal cord injury"	-Inf	0.418287994876429	"Spinal cord injury"	""	0
"Quercetin and Nf kB AP 1 induced apoptosis"	1.82354386283041	0.20217327519646	"Quercetin and Nf kB AP 1 induced apoptosis"	"3551"	1
"Dopamine metabolism"	-Inf	1	"Dopamine metabolism"	""	0
"Alpha 6 beta 4 signaling pathway"	-Inf	1	"Alpha 6 beta 4 signaling pathway"	""	0
"Retinoblastoma gene in cancer"	-Inf	0.638281168619088	"Retinoblastoma gene in cancer"	""	0
"Amyotrophic lateral sclerosis ALS "	-Inf	1	"Amyotrophic lateral sclerosis ALS "	""	0
"TCA cycle and deficiency of pyruvate dehydrogenase complex PDHc "	1.82354386283041	0.20217327519646	"TCA cycle and deficiency of pyruvate dehydrogenase complex PDHc "	"48"	1
"HIF1A and PPARG regulation of glycolysis"	-Inf	1	"HIF1A and PPARG regulation of glycolysis"	""	0
"Small ligand GPCRs"	-Inf	1	"Small ligand GPCRs"	""	0
"NAD biosynthesis II from tryptophan "	-Inf	1	"NAD biosynthesis II from tryptophan "	""	0
"Diclofenac metabolic pathway"	-Inf	1	"Diclofenac metabolic pathway"	""	0
"Nanomaterial induced apoptosis"	-Inf	1	"Nanomaterial induced apoptosis"	""	0
"Nanoparticle triggered autophagic cell death"	-Inf	1	"Nanoparticle triggered autophagic cell death"	""	0
"Nanoparticle triggered regulated necrosis"	-Inf	1	"Nanoparticle triggered regulated necrosis"	""	0
"ATM signaling pathway"	-Inf	1	"ATM signaling pathway"	""	0
"Trans sulfuration one carbon metabolism and related pathways"	-Inf	1	"Trans sulfuration one carbon metabolism and related pathways"	""	0
"PDGF pathway"	0.590883106040136	0.431904339275828	"PDGF pathway"	"7409"	1
"Glycerophospholipid biosynthetic pathway"	-Inf	1	"Glycerophospholipid biosynthetic pathway"	""	0
"Colchicine metabolic pathway"	-Inf	1	"Colchicine metabolic pathway"	""	0
"Apoptosis"	0.545559115530646	0.350059100766925	"Apoptosis"	"7186;3551"	2
"Sulindac metabolic pathway"	-Inf	1	"Sulindac metabolic pathway"	""	0
"Polycystic kidney disease pathway"	-0.37808999833924	1	"Polycystic kidney disease pathway"	"3551"	1
"Primary focal segmental glomerulosclerosis FSGS "	-Inf	0.627993773769284	"Primary focal segmental glomerulosclerosis FSGS "	""	0
"T cell receptor and co stimulatory signaling"	-Inf	1	"T cell receptor and co stimulatory signaling"	""	0
"Aryl hydrocarbon receptor pathway"	-Inf	0.6285505828186	"Aryl hydrocarbon receptor pathway"	""	0
"Gastric acid production"	-Inf	1	"Gastric acid production"	""	0
"S1P receptor signal transduction"	-Inf	1	"S1P receptor signal transduction"	""	0
"Ebstein Barr virus LMP1 signaling"	1.01618894077281	0.277338416506654	"Ebstein Barr virus LMP1 signaling"	"3551"	1
"Common pathways underlying drug addiction"	-Inf	1	"Common pathways underlying drug addiction"	""	0
"Interleukin 1 IL 1 structural pathway"	1.47304661574628	0.149931286374657	"Interleukin 1 IL 1 structural pathway"	"5600;3551"	2
"Aripiprazole metabolic pathway"	-Inf	1	"Aripiprazole metabolic pathway"	""	0
"Nanoparticle mediated activation of receptor signaling"	1.33811703566017	0.326686008829877	"Nanoparticle mediated activation of receptor signaling"	"5600"	1
"Heroin metabolism"	-Inf	1	"Heroin metabolism"	""	0
"Lidocaine metabolism"	-Inf	1	"Lidocaine metabolism"	""	0
"Notch signaling"	0.686040339080476	0.463216306722428	"Notch signaling"	"23220"	1
"Blood clotting cascade"	-Inf	1	"Blood clotting cascade"	""	0
"Cardiac hypertrophic response"	0.168192034217857	0.540772560030998	"Cardiac hypertrophic response"	"3551"	1
"Selenium metabolism and selenoproteins"	-Inf	1	"Selenium metabolism and selenoproteins"	""	0
"exRNA mechanism of action and biogenesis"	-Inf	1	"exRNA mechanism of action and biogenesis"	""	0
"Complement system"	-Inf	0.645297173100084	"Complement system"	""	0
"Mammary gland development pathway Embryonic development Stage 1 of 4 "	-Inf	1	"Mammary gland development pathway Embryonic development Stage 1 of 4 "	""	0
"Mammary gland development pathway Puberty Stage 2 of 4 "	-Inf	1	"Mammary gland development pathway Puberty Stage 2 of 4 "	""	0
"Mammary gland development pathway Involution Stage 4 of 4 "	-Inf	1	"Mammary gland development pathway Involution Stage 4 of 4 "	""	0
"Felbamate metabolism"	-Inf	1	"Felbamate metabolism"	""	0
"Mammary gland development pathway Pregnancy and lactation Stage 3 of 4 "	-Inf	1	"Mammary gland development pathway Pregnancy and lactation Stage 3 of 4 "	""	0
"Cocaine metabolism"	-Inf	1	"Cocaine metabolism"	""	0
"Bladder cancer"	-Inf	1	"Bladder cancer"	""	0
"Hair follicle development organogenesis part 2 of 3"	-Inf	1	"Hair follicle development organogenesis part 2 of 3"	""	0
"Hair follicle development cytodifferentiation part 3 of 3"	-Inf	0.636273867508579	"Hair follicle development cytodifferentiation part 3 of 3"	""	0
"PCSK9 mediated LDL receptor degradation"	-Inf	1	"PCSK9 mediated LDL receptor degradation"	""	0
"Pluripotent stem cell differentiation pathway"	-Inf	1	"Pluripotent stem cell differentiation pathway"	""	0
"Hematopoietic stem cell differentiation"	0.736081021580071	0.194892283581721	"Hematopoietic stem cell differentiation"	"1437;7409"	2
"Endoderm differentiation"	-Inf	0.272747407594444	"Endoderm differentiation"	""	0
"Gene regulatory network modeling somitogenesis "	-Inf	1	"Gene regulatory network modeling somitogenesis "	""	0
"Dopaminergic neurogenesis"	-Inf	1	"Dopaminergic neurogenesis"	""	0
"Mesodermal commitment pathway"	-Inf	0.275197618274908	"Mesodermal commitment pathway"	""	0
"Ectoderm differentiation"	-1.09293278160731	0.725097779548923	"Ectoderm differentiation"	"7020"	1
"IL 3 signaling pathway"	0.238581362109255	0.507003236701657	"IL 3 signaling pathway"	"7409"	1
"Apoptosis related network due to altered Notch3 in ovarian cancer"	-Inf	1	"Apoptosis related network due to altered Notch3 in ovarian cancer"	""	0
"IL1 and megakaryocytes in obesity"	-Inf	1	"IL1 and megakaryocytes in obesity"	""	0
"TCA cycle nutrient use and invasiveness of ovarian cancer"	-Inf	1	"TCA cycle nutrient use and invasiveness of ovarian cancer"	""	0
"Extracellular vesicle mediated signaling in recipient cells"	-Inf	1	"Extracellular vesicle mediated signaling in recipient cells"	""	0
"Liver X receptor pathway"	-Inf	1	"Liver X receptor pathway"	""	0
"Constitutive androstane receptor pathway"	-Inf	1	"Constitutive androstane receptor pathway"	""	0
"Pregnane X receptor pathway"	-Inf	1	"Pregnane X receptor pathway"	""	0
"Vitamin D receptor pathway"	-Inf	0.116690536170186	"Vitamin D receptor pathway"	""	0
"PPAR alpha pathway"	-Inf	1	"PPAR alpha pathway"	""	0
"Farnesoid X receptor pathway"	-Inf	1	"Farnesoid X receptor pathway"	""	0
"Nod like receptor NLR signaling pathway"	2.97554695627546	0.119262502115401	"Nod like receptor NLR signaling pathway"	"3551"	1
"Glucocorticoid receptor pathway"	-Inf	0.627981142945151	"Glucocorticoid receptor pathway"	""	0
"Estrogen receptor pathway"	-Inf	1	"Estrogen receptor pathway"	""	0
"Nuclear receptors meta pathway"	-Inf	0.0234399942389133	"Nuclear receptors meta pathway"	""	0
"NRF2 pathway"	-Inf	0.270100640188893	"NRF2 pathway"	""	0
"Oxytocin signaling"	-Inf	1	"Oxytocin signaling"	""	0
"Myometrial relaxation and contraction pathways"	-Inf	0.283546504506833	"Myometrial relaxation and contraction pathways"	""	0
"Differentiation of white and brown adipocyte"	-Inf	1	"Differentiation of white and brown adipocyte"	""	0
"miRNA targets in ECM and membrane receptors"	-Inf	1	"miRNA targets in ECM and membrane receptors"	""	0
"Interactome of polycomb repressive complex 2 PRC2 "	-Inf	1	"Interactome of polycomb repressive complex 2 PRC2 "	""	0
"DDX1 as a regulatory component of the Drosha microprocessor"	-Inf	1	"DDX1 as a regulatory component of the Drosha microprocessor"	""	0
"Hypoxia mediated EMT and stemness"	-Inf	1	"Hypoxia mediated EMT and stemness"	""	0
"Nuclear receptors in lipid metabolism and toxicity"	-Inf	1	"Nuclear receptors in lipid metabolism and toxicity"	""	0
"Transcriptional activation by NRF2 in response to phytochemicals"	-Inf	1	"Transcriptional activation by NRF2 in response to phytochemicals"	""	0
"Kit receptor signaling pathway"	0.10107783835932	0.527549263309558	"Kit receptor signaling pathway"	"7409"	1
"Focal adhesion"	-0.498384232056951	1	"Focal adhesion"	"7409;6725"	2
"Ketone bodies synthesis and degradation"	-Inf	1	"Ketone bodies synthesis and degradation"	""	0
"Hepatocyte growth factor receptor signaling"	-Inf	1	"Hepatocyte growth factor receptor signaling"	""	0
"Fas ligand pathway and stress induction of heat shock proteins"	-Inf	1	"Fas ligand pathway and stress induction of heat shock proteins"	""	0
"Osteoblast signaling"	-Inf	1	"Osteoblast signaling"	""	0
"Triacylglyceride synthesis"	-Inf	1	"Triacylglyceride synthesis"	""	0
"Copper homeostasis"	0.262828908355932	0.513948497129324	"Copper homeostasis"	"54739"	1
"Overview of nanoparticle effects"	-Inf	1	"Overview of nanoparticle effects"	""	0
"EV release from cardiac cells and their functional effects"	-Inf	1	"EV release from cardiac cells and their functional effects"	""	0
"Melatonin metabolism and effects"	0.936018592088824	0.40723794475413	"Melatonin metabolism and effects"	"5187"	1
"let 7 inhibition of ES cell reprogramming"	-Inf	1	"let 7 inhibition of ES cell reprogramming"	""	0
"Dual hijack model of Vif in HIV infection"	-Inf	1	"Dual hijack model of Vif in HIV infection"	""	0
"MFAP5 mediated ovarian cancer cell motility and invasiveness"	-Inf	1	"MFAP5 mediated ovarian cancer cell motility and invasiveness"	""	0
"eIF5A regulation in response to inhibition of the nuclear export system"	-Inf	1	"eIF5A regulation in response to inhibition of the nuclear export system"	""	0
"RAC1 PAK1 p38 MMP2 pathway"	0.878685417022872	0.24648914635702	"RAC1 PAK1 p38 MMP2 pathway"	"5600;3551"	2
"GPCRs class B secretin like"	1.50161576794305	0.287486720546743	"GPCRs class B secretin like"	"2696"	1
"Ovarian infertility"	-Inf	1	"Ovarian infertility"	""	0
"FTO obesity variant mechanism"	-Inf	1	"FTO obesity variant mechanism"	""	0
"Evolocumab mechanism to reduce LDL cholesterol"	-Inf	1	"Evolocumab mechanism to reduce LDL cholesterol"	""	0
"NOTCH1 regulation of endothelial cell calcification"	-Inf	1	"NOTCH1 regulation of endothelial cell calcification"	""	0
"Initiation of transcription and translation elongation at the HIV 1 LTR"	-Inf	1	"Initiation of transcription and translation elongation at the HIV 1 LTR"	""	0
"G protein signaling pathways"	-0.409116893959864	1	"G protein signaling pathways"	"9138"	1
"Pre implantation embryo"	-Inf	1	"Pre implantation embryo"	""	0
"Zinc homeostasis"	-Inf	1	"Zinc homeostasis"	""	0
"Fatty acid biosynthesis"	-Inf	1	"Fatty acid biosynthesis"	""	0
"Methionine de novo and salvage pathway"	-Inf	1	"Methionine de novo and salvage pathway"	""	0
"MECP2 and associated Rett syndrome"	-Inf	0.62829594280072	"MECP2 and associated Rett syndrome"	""	0
"Cytosine methylation"	-Inf	1	"Cytosine methylation"	""	0
"Sleep regulation"	-Inf	1	"Sleep regulation"	""	0
"MicroRNA for targeting cancer growth and vascularization in glioblastoma"	-Inf	1	"MicroRNA for targeting cancer growth and vascularization in glioblastoma"	""	0
"Circadian rhythm genes"	-1.65542794220253	0.533303374112166	"Circadian rhythm genes"	"5187"	1
"mir 124 predicted interactions with cell cycle and differentiation "	-Inf	1	"mir 124 predicted interactions with cell cycle and differentiation "	""	0
"miR 517 relationship with ARCN1 and USP1"	-Inf	1	"miR 517 relationship with ARCN1 and USP1"	""	0
"Transcription factor regulation in adipogenesis"	-Inf	1	"Transcription factor regulation in adipogenesis"	""	0
"Lipid particles composition"	-Inf	1	"Lipid particles composition"	""	0
"Photodynamic therapy induced AP 1 survival signaling"	1.2874909625902	0.159740215318309	"Photodynamic therapy induced AP 1 survival signaling"	"5600;7186"	2
"Photodynamic therapy induced NFE2L2 NRF2 survival signaling"	1.44503223957668	0.277338416506654	"Photodynamic therapy induced NFE2L2 NRF2 survival signaling"	"5600"	1
"Photodynamic therapy induced unfolded protein response"	-Inf	1	"Photodynamic therapy induced unfolded protein response"	""	0
"Photodynamic therapy induced HIF 1 survival signaling"	-Inf	1	"Photodynamic therapy induced HIF 1 survival signaling"	""	0
"Photodynamic therapy induced NF kB survival signaling"	1.68604033908048	0.0858215504148791	"Photodynamic therapy induced NF kB survival signaling"	"1437;3551"	2
"Lung fibrosis"	0.145471957717773	0.59587822269803	"Lung fibrosis"	"1437"	1
"Gut liver indole metabolism "	-Inf	1	"Gut liver indole metabolism "	""	0
"Wnt signaling pathway"	-Inf	1	"Wnt signaling pathway"	""	0
"NAD metabolism sirtuins and aging"	-Inf	1	"NAD metabolism sirtuins and aging"	""	0
"Caffeine and theobromine metabolism"	-Inf	1	"Caffeine and theobromine metabolism"	""	0
"Insulin signaling in adipocytes normal condition "	-Inf	1	"Insulin signaling in adipocytes normal condition "	""	0
"Insulin signaling in adipocytes diabetic condition "	-Inf	1	"Insulin signaling in adipocytes diabetic condition "	""	0
"IL6 signaling pathway"	0.191275647330898	0.455552568330103	"IL6 signaling pathway"	"7409"	1
"Imatinib and chronic myeloid leukemia"	-Inf	1	"Imatinib and chronic myeloid leukemia"	""	0
"NAD metabolism"	-Inf	1	"NAD metabolism"	""	0
"NAD biosynthetic pathways"	-Inf	1	"NAD biosynthetic pathways"	""	0
"Hepatitis C and hepatocellular carcinoma"	-Inf	1	"Hepatitis C and hepatocellular carcinoma"	""	0
"Pathways affected in adenoid cystic carcinoma"	1.01618894077281	0.230908288400413	"Pathways affected in adenoid cystic carcinoma"	"23135;23220"	2
"Hypothetical craniofacial development pathway"	2.97554695627546	0.106740666721343	"Hypothetical craniofacial development pathway"	"7020"	1
"Interleukin 1 induced activation of NF kB"	-Inf	1	"Interleukin 1 induced activation of NF kB"	""	0
"Hematopoietic stem cell gene regulation by GABP alpha beta complex"	-Inf	1	"Hematopoietic stem cell gene regulation by GABP alpha beta complex"	""	0
"Wnt beta catenin signaling pathway in leukemia"	-Inf	1	"Wnt beta catenin signaling pathway in leukemia"	""	0
"TGF beta signaling pathway"	-Inf	0.267084222336414	"TGF beta signaling pathway"	""	0
"Regulation of Wnt B catenin signaling by small molecule compounds"	-Inf	1	"Regulation of Wnt B catenin signaling by small molecule compounds"	""	0
"Metabolism of dichloroethylene by CYP450"	-Inf	1	"Metabolism of dichloroethylene by CYP450"	""	0
"Hypothesized pathways in pathogenesis of cardiovascular disease"	1.3905844555543	0.29749369331376	"Hypothesized pathways in pathogenesis of cardiovascular disease"	"2201"	1
"Interactions between LOXL4 and oxidative stress pathway"	-Inf	1	"Interactions between LOXL4 and oxidative stress pathway"	""	0
"lncRNA mediated mechanisms of therapeutic resistance"	-Inf	1	"lncRNA mediated mechanisms of therapeutic resistance"	""	0
"Tgif disruption of Shh signaling"	-Inf	1	"Tgif disruption of Shh signaling"	""	0
"BDNF TrkB signaling"	-Inf	1	"BDNF TrkB signaling"	""	0
"Amplification and expansion of oncogenic pathways as metastatic traits"	-Inf	1	"Amplification and expansion of oncogenic pathways as metastatic traits"	""	0
"Cell type dependent selectivity of CCK2R signaling"	-Inf	1	"Cell type dependent selectivity of CCK2R signaling"	""	0
"Mitochondrial long chain fatty acid beta oxidation"	-Inf	1	"Mitochondrial long chain fatty acid beta oxidation"	""	0
"Physico chemical features and toxicity associated pathways"	-Inf	1	"Physico chemical features and toxicity associated pathways"	""	0
"MAPK signaling pathway"	-0.258250228333236	1	"MAPK signaling pathway"	"5600;7186;3551"	3
"Striated muscle contraction pathway"	-Inf	1	"Striated muscle contraction pathway"	""	0
"Apoptosis modulation by HSP70"	-Inf	1	"Apoptosis modulation by HSP70"	""	0
"PI3K AKT mTOR signaling pathway and therapeutic opportunities in prostate cancer"	-Inf	1	"PI3K AKT mTOR signaling pathway and therapeutic opportunities in prostate cancer"	""	0
"Canonical and non canonical Notch signaling"	-Inf	1	"Canonical and non canonical Notch signaling"	""	0
"MAPK and NFkB signaling pathways inhibited by Yersinia YopJ"	2.23858136210925	0.155793104944555	"MAPK and NFkB signaling pathways inhibited by Yersinia YopJ"	"3551"	1
"Factors and pathways affecting insulin like growth factor IGF1 Akt signaling"	-Inf	1	"Factors and pathways affecting insulin like growth factor IGF1 Akt signaling"	""	0
"TLR4 signaling and tolerance"	1.14547195771777	0.326686008829877	"TLR4 signaling and tolerance"	"3551"	1
"ERK pathway in Huntington 39 s disease"	-Inf	1	"ERK pathway in Huntington 39 s disease"	""	0
"Toll like receptor signaling related to MyD88"	0.975546956275461	0.354675023951211	"Toll like receptor signaling related to MyD88"	"3551"	1
"TGF beta signaling in thyroid cells for epithelial mesenchymal transition"	-Inf	1	"TGF beta signaling in thyroid cells for epithelial mesenchymal transition"	""	0
"T cell antigen receptor TCR pathway during Staphylococcus aureus infection"	1.12310414468932	0.215399063328743	"T cell antigen receptor TCR pathway during Staphylococcus aureus infection"	"1437;3551"	2
"Novel intracellular components of RIG I like receptor pathway"	1.68604033908048	0.051513047915913	"Novel intracellular components of RIG I like receptor pathway"	"5600;7186;3551"	3
"Cannabinoid receptor signaling"	0.78791995309969	0.336146909166309	"Cannabinoid receptor signaling"	"5600"	1
"Valproic acid pathway"	-Inf	1	"Valproic acid pathway"	""	0
"Regulation of apoptosis by parathyroid hormone related protein"	-Inf	1	"Regulation of apoptosis by parathyroid hormone related protein"	""	0
"RIOK1 and RIOK2 in EGFR and PI3K mediated tumorigenesis"	-Inf	1	"RIOK1 and RIOK2 in EGFR and PI3K mediated tumorigenesis"	""	0
"Canonical and non canonical TGF B signaling"	-Inf	1	"Canonical and non canonical TGF B signaling"	""	0
"ATR signaling"	-Inf	1	"ATR signaling"	""	0
"BMP2 WNT4 FOXO1 pathway in primary endometrial stromal cell differentiation"	-Inf	1	"BMP2 WNT4 FOXO1 pathway in primary endometrial stromal cell differentiation"	""	0
"MYD88 distinct input output pathway"	-Inf	1	"MYD88 distinct input output pathway"	""	0
"ATM signaling in development and disease "	0.191275647330898	0.485571531720117	"ATM signaling in development and disease "	"5600"	1
"4 hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression"	-Inf	1	"4 hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression"	""	0
"VEGFA VEGFR2 signaling"	-Inf	0.00472071450393893	"VEGFA VEGFR2 signaling"	""	0
"Nanomaterial induced inflammasome activation"	-Inf	1	"Nanomaterial induced inflammasome activation"	""	0
"Benzene metabolism"	-Inf	1	"Benzene metabolism"	""	0
"Development of pulmonary dendritic cells and macrophage subsets"	1.01618894077281	0.167632895222882	"Development of pulmonary dendritic cells and macrophage subsets"	"1437"	1
"Development and heterogeneity of the ILC family"	-Inf	1	"Development and heterogeneity of the ILC family"	""	0
"Dengue 2 interactions with complement and coagulation cascades"	-Inf	1	"Dengue 2 interactions with complement and coagulation cascades"	""	0
"Mitochondrial gene expression"	1.89754444427419	0.235291895147978	"Mitochondrial gene expression"	"23082"	1
"Angiopoietin like protein 8 regulatory pathway"	-1.06398140791118	1	"Angiopoietin like protein 8 regulatory pathway"	"5600"	1
"Hfe effect on hepcidin production"	-Inf	1	"Hfe effect on hepcidin production"	""	0
"Amino acid metabolism"	-Inf	0.640461481541254	"Amino acid metabolism"	""	0
"ApoE and miR 146 in inflammation and atherosclerosis"	-Inf	1	"ApoE and miR 146 in inflammation and atherosclerosis"	""	0
"BMP signaling in eyelid development"	-Inf	1	"BMP signaling in eyelid development"	""	0
"Chemokine signaling pathway"	-0.322133592365224	1	"Chemokine signaling pathway"	"7409;3551"	2
"EDA signaling in hair follicle development"	-Inf	1	"EDA signaling in hair follicle development"	""	0
"Embryonic stem cell pluripotency pathways"	-Inf	0.415128990093839	"Embryonic stem cell pluripotency pathways"	""	0
"Focal adhesion PI3K Akt mTOR signaling pathway"	-2.15373606066951	0.132381882651855	"Focal adhesion PI3K Akt mTOR signaling pathway"	"3551"	1
"Kennedy pathway from sphingolipids"	-Inf	1	"Kennedy pathway from sphingolipids"	""	0
"Leptin and adiponectin"	-Inf	1	"Leptin and adiponectin"	""	0
"Leptin insulin signaling overlap"	-Inf	1	"Leptin insulin signaling overlap"	""	0
"Microglia pathogen phagocytosis pathway"	0.560509456996617	0.431904339275828	"Microglia pathogen phagocytosis pathway"	"7409"	1
"miR 222 in exercise induced cardiac growth"	-Inf	1	"miR 222 in exercise induced cardiac growth"	""	0
"One carbon metabolism and related pathways"	-Inf	1	"One carbon metabolism and related pathways"	""	0
"Oxidative damage response"	0.823543862830411	0.431904339275828	"Oxidative damage response"	"7186"	1
"PPAR signaling pathway"	-Inf	1	"PPAR signaling pathway"	""	0
"Robo4 and VEGF signaling pathways crosstalk"	-Inf	1	"Robo4 and VEGF signaling pathways crosstalk"	""	0
"Serotonin and anxiety related events"	-Inf	1	"Serotonin and anxiety related events"	""	0
"TYROBP causal network in microglia"	-Inf	0.999999999999999	"TYROBP causal network in microglia"	""	0
"Serotonin and anxiety"	-Inf	1	"Serotonin and anxiety"	""	0
"IL 4 signaling pathway"	1.14547195771777	0.154820412638127	"IL 4 signaling pathway"	"5600;3551"	2
"mRNA protein and metabolite inducation pathway by cyclosporin A"	-Inf	1	"mRNA protein and metabolite inducation pathway by cyclosporin A"	""	0
"GPR40 pathway"	-Inf	1	"GPR40 pathway"	""	0
"DNA IR double strand breaks and cellular response via ATM"	-Inf	1	"DNA IR double strand breaks and cellular response via ATM"	""	0
"Mevalonate pathway"	-Inf	1	"Mevalonate pathway"	""	0
"Lipid metabolism pathway"	-Inf	1	"Lipid metabolism pathway"	""	0
"miR 509 3p alteration of YAP1 ECM axis"	-Inf	1	"miR 509 3p alteration of YAP1 ECM axis"	""	0
"H19 action Rb E2F1 signaling and CDK Beta catenin activity"	-Inf	1	"H19 action Rb E2F1 signaling and CDK Beta catenin activity"	""	0
"OSX and miRNAs in tooth development"	-Inf	1	"OSX and miRNAs in tooth development"	""	0
"PDGFR beta pathway"	-Inf	1	"PDGFR beta pathway"	""	0
"miRNA regulation of prostate cancer signaling pathways"	-Inf	1	"miRNA regulation of prostate cancer signaling pathways"	""	0
"miRNA regulation of p53 pathway in prostate cancer"	-Inf	1	"miRNA regulation of p53 pathway in prostate cancer"	""	0
"Wnt signaling pathway and pluripotency"	-0.56877355994835	1	"Wnt signaling pathway and pluripotency"	"333926"	1
"Prion disease pathway"	-Inf	1	"Prion disease pathway"	""	0
"Ethanol effects on histone modifications"	-Inf	1	"Ethanol effects on histone modifications"	""	0
"Prader Willi and Angelman syndrome"	-Inf	0.409582945639173	"Prader Willi and Angelman syndrome"	""	0
"p38 MAPK signaling pathway"	0.936018592088824	0.390206652543109	"p38 MAPK signaling pathway"	"7186"	1
"NO cGMP PKG mediated neuroprotection"	-Inf	1	"NO cGMP PKG mediated neuroprotection"	""	0
"DNA IR damage and cellular response via ATR"	-0.526953384253722	1	"DNA IR damage and cellular response via ATR"	"22897"	1
"Clear cell renal cell carcinoma pathways"	-Inf	0.634451186641739	"Clear cell renal cell carcinoma pathways"	""	0
"SCFA and skeletal muscle substrate metabolism"	-Inf	1	"SCFA and skeletal muscle substrate metabolism"	""	0
"Eukaryotic transcription initiation"	-Inf	1	"Eukaryotic transcription initiation"	""	0
"Oxidative stress response"	-Inf	1	"Oxidative stress response"	""	0
"Exercise induced circadian regulation"	0.338117035660169	0.492816145652106	"Exercise induced circadian regulation"	"5187"	1
"mRNA processing"	-0.920617232739999	1	"mRNA processing"	"3276"	1
"Fibrin complement receptor 3 signaling pathway"	0.445032239576681	0.455552568330103	"Fibrin complement receptor 3 signaling pathway"	"3551"	1
"PI3K AKT mTOR vitamin D3 signaling"	-Inf	1	"PI3K AKT mTOR vitamin D3 signaling"	""	0
"Metabolism of sphingolipids in ER and Golgi apparatus"	-Inf	1	"Metabolism of sphingolipids in ER and Golgi apparatus"	""	0
"Macrophage markers"	-Inf	1	"Macrophage markers"	""	0
"PTF1A related regulatory pathway"	-Inf	1	"PTF1A related regulatory pathway"	""	0
"Splicing factor NOVA regulated synaptic proteins"	-Inf	1	"Splicing factor NOVA regulated synaptic proteins"	""	0
"White fat cell differentiation"	-Inf	1	"White fat cell differentiation"	""	0
"Wnt signaling in kidney disease"	-Inf	1	"Wnt signaling in kidney disease"	""	0
"Degradation pathway of sphingolipids including diseases"	-Inf	1	"Degradation pathway of sphingolipids including diseases"	""	0
"Endometrial cancer"	-Inf	1	"Endometrial cancer"	""	0
"Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine"	-Inf	1	"Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine"	""	0
"GABA metabolism aka GHB "	-Inf	1	"GABA metabolism aka GHB "	""	0
"GABA receptor signaling"	0.78791995309969	0.354675023951211	"GABA receptor signaling"	"2564"	1
"PI3K Akt signaling pathway"	-2.28498059394776	0.0941043538714113	"PI3K Akt signaling pathway"	"3551"	1
"Metabolism of tetrahydrocannabinol THC "	-Inf	1	"Metabolism of tetrahydrocannabinol THC "	""	0
"Somatroph axis GH and its relationship to dietary restriction and aging"	-Inf	1	"Somatroph axis GH and its relationship to dietary restriction and aging"	""	0
"Mevalonate arm of cholesterol biosynthesis pathway with inhibitors"	-Inf	1	"Mevalonate arm of cholesterol biosynthesis pathway with inhibitors"	""	0
"Mevalonate arm of cholesterol biosynthesis pathway"	-Inf	1	"Mevalonate arm of cholesterol biosynthesis pathway"	""	0
"Caloric restriction and aging"	-Inf	1	"Caloric restriction and aging"	""	0
"Hormonal control of pubertal growth spurt"	-Inf	1	"Hormonal control of pubertal growth spurt"	""	0
"Immune response to tuberculosis"	-Inf	1	"Immune response to tuberculosis"	""	0
"Tumor suppressor activity of SMARCB1"	-Inf	1	"Tumor suppressor activity of SMARCB1"	""	0
"MET in type 1 papillary renal cell carcinoma"	-Inf	1	"MET in type 1 papillary renal cell carcinoma"	""	0
"Hereditary leiomyomatosis and renal cell carcinoma pathway"	-Inf	1	"Hereditary leiomyomatosis and renal cell carcinoma pathway"	""	0
"Tryptophan catabolism leading to NAD production"	-Inf	1	"Tryptophan catabolism leading to NAD production"	""	0
"Transcriptional cascade regulating adipogenesis"	-Inf	1	"Transcriptional cascade regulating adipogenesis"	""	0
"Chromosomal and microsatellite instability in colorectal cancer "	-Inf	0.628109680753719	"Chromosomal and microsatellite instability in colorectal cancer "	""	0
"Ebola virus infection in host"	-0.963052499060396	1	"Ebola virus infection in host"	"7020"	1
"MAPK cascade"	-Inf	1	"MAPK cascade"	""	0
"Neurotransmitter disorders"	-Inf	1	"Neurotransmitter disorders"	""	0
"Phosphodiesterases in neuronal function"	-Inf	1	"Phosphodiesterases in neuronal function"	""	0
"Ras signaling"	-1.4765798617386	0.523612350929938	"Ras signaling"	"3551"	1
"Purine metabolism and related disorders"	-Inf	1	"Purine metabolism and related disorders"	""	0
"Pyrimidine metabolism and related diseases"	-Inf	1	"Pyrimidine metabolism and related diseases"	""	0
"Vitamin B6 dependent and responsive disorders"	-Inf	1	"Vitamin B6 dependent and responsive disorders"	""	0
"Acrylamide biotransformation and exposure biomarkers"	-Inf	1	"Acrylamide biotransformation and exposure biomarkers"	""	0
"Krebs cycle disorders"	-Inf	1	"Krebs cycle disorders"	""	0
"Flavan 3 ol metabolic pathway"	-Inf	1	"Flavan 3 ol metabolic pathway"	""	0
"Epithelial to mesenchymal transition in colorectal cancer"	-1.39368685339026	0.729991235308593	"Epithelial to mesenchymal transition in colorectal cancer"	"5600"	1
"Regulation of sister chromatid separation at the metaphase anaphase transition"	-Inf	1	"Regulation of sister chromatid separation at the metaphase anaphase transition"	""	0
"Type 2 papillary renal cell carcinoma"	-Inf	1	"Type 2 papillary renal cell carcinoma"	""	0
"Hedgehog signaling pathway"	-0.280792796984325	0.485571531720117	"Hedgehog signaling pathway"	"374654"	1
"Non small cell lung cancer"	-Inf	0.627993773769284	"Non small cell lung cancer"	""	0
"lncRNA in canonical Wnt signaling and colorectal cancer"	-0.56877355994835	1	"lncRNA in canonical Wnt signaling and colorectal cancer"	"7020"	1
"Disorders of folate metabolism and transport"	-Inf	1	"Disorders of folate metabolism and transport"	""	0
"Breast cancer pathway"	-Inf	0.282365496844734	"Breast cancer pathway"	""	0
"Pancreatic adenocarcinoma pathway"	-0.512739525034021	1	"Pancreatic adenocarcinoma pathway"	"3551"	1
"Ethanol metabolism production of ROS by CYP2E1"	-Inf	1	"Ethanol metabolism production of ROS by CYP2E1"	""	0
"Vitamin B12 disorders"	-Inf	1	"Vitamin B12 disorders"	""	0
"Wnt signaling"	-Inf	0.412426342728996	"Wnt signaling"	""	0
"Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer"	-Inf	1	"Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer"	""	0
"MTHFR deficiency"	-Inf	1	"MTHFR deficiency"	""	0
"Metabolic reprogramming in colon cancer"	-Inf	1	"Metabolic reprogramming in colon cancer"	""	0
"Methionine metabolism leading to sulfur amino acids and related disorders"	-Inf	1	"Methionine metabolism leading to sulfur amino acids and related disorders"	""	0
"Thiamine metabolic pathways"	-Inf	1	"Thiamine metabolic pathways"	""	0
"Acute viral myocarditis"	-Inf	0.634451186641739	"Acute viral myocarditis"	""	0
"Lamin A processing pathway"	-Inf	1	"Lamin A processing pathway"	""	0
"Oxidation by cytochrome P450"	-Inf	1	"Oxidation by cytochrome P450"	""	0
"Statin inhibition of cholesterol production"	-Inf	1	"Statin inhibition of cholesterol production"	""	0
"Extracellular vesicles in the crosstalk of cardiac cells"	1.68604033908048	0.256609871505098	"Extracellular vesicles in the crosstalk of cardiac cells"	"10611"	1
"Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells"	-Inf	1	"Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells"	""	0
"Oligodendrocyte specification and differentiation leading to myelin components for CNS"	-Inf	1	"Oligodendrocyte specification and differentiation leading to myelin components for CNS"	""	0
"Rett syndrome"	0.501615767943049	0.492816145652106	"Rett syndrome"	"9001"	1
"Ferroptosis"	-Inf	1	"Ferroptosis"	""	0
"miRNA degrading enzymes"	-Inf	1	"miRNA degrading enzymes"	""	0
"Mitochondrial fatty acid synthesis pathway"	-Inf	1	"Mitochondrial fatty acid synthesis pathway"	""	0
"Effect of progerin on genes involved in progeria"	-Inf	1	"Effect of progerin on genes involved in progeria"	""	0
"Thermogenesis"	-0.648943908632333	1	"Thermogenesis"	"5600"	1
"Mitochondrial complex I assembly model OXPHOS system"	-Inf	1	"Mitochondrial complex I assembly model OXPHOS system"	""	0
"miRNA role in immune response in sepsis"	-0.362322682480923	0.59587822269803	"miRNA role in immune response in sepsis"	"3551"	1
"Neovascularization processes"	-Inf	1	"Neovascularization processes"	""	0
"ncRNAs involved in Wnt signaling in hepatocellular carcinoma"	-Inf	0.638281168619088	"ncRNAs involved in Wnt signaling in hepatocellular carcinoma"	""	0
"ncRNAs involved in STAT3 signaling in hepatocellular carcinoma"	-Inf	1	"ncRNAs involved in STAT3 signaling in hepatocellular carcinoma"	""	0
"Non genomic actions of 1 25 dihydroxyvitamin D3"	0.530762113602565	0.282946553656207	"Non genomic actions of 1 25 dihydroxyvitamin D3"	"5600;3551"	2
"Vitamins A and D action mechanisms"	-Inf	1	"Vitamins A and D action mechanisms"	""	0
"Ciliary landscape"	-0.693731830379171	0.771489740013743	"Ciliary landscape"	"11020;7020"	2
"NRF2 ARE regulation"	-Inf	1	"NRF2 ARE regulation"	""	0
"EGF EGFR signaling pathway"	0.137977421170849	0.491701304932042	"EGF EGFR signaling pathway"	"10401;7409;9138"	3
"Non homologous end joining"	-Inf	1	"Non homologous end joining"	""	0
"Bile acids synthesis and enterohepatic circulation "	-Inf	1	"Bile acids synthesis and enterohepatic circulation "	""	0
"Nonalcoholic fatty liver disease"	-0.176456137169589	1	"Nonalcoholic fatty liver disease"	"7186;3551"	2
"Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors"	-Inf	1	"Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors"	""	0
"MicroRNA network associated with chronic lymphocytic leukemia"	-Inf	1	"MicroRNA network associated with chronic lymphocytic leukemia"	""	0
"FABP4 in ovarian cancer"	-Inf	1	"FABP4 in ovarian cancer"	""	0
"Platelet mediated interactions with vascular and circulating cells"	-Inf	1	"Platelet mediated interactions with vascular and circulating cells"	""	0
"LTF danger signal response pathway"	-Inf	1	"LTF danger signal response pathway"	""	0
"Supression of HMGB1 mediated inflammation by THBD"	2.23858136210925	0.119262502115401	"Supression of HMGB1 mediated inflammation by THBD"	"3551"	1
"Altered glycosylation of MUC1 in tumor microenvironment"	2.23858136210925	0.119262502115401	"Altered glycosylation of MUC1 in tumor microenvironment"	"3551"	1
"Resistin as a regulator of inflammation"	0.897544444274188	0.372690244782872	"Resistin as a regulator of inflammation"	"3551"	1
"Vitamin D in inflammatory diseases"	1.23858136210925	0.267046802285052	"Vitamin D in inflammatory diseases"	"3551"	1
"Relationship between inflammation COX 2 and EGFR"	-Inf	1	"Relationship between inflammation COX 2 and EGFR"	""	0
"Control of immune tolerance by vasoactive intestinal peptide"	-Inf	1	"Control of immune tolerance by vasoactive intestinal peptide"	""	0
"Cells and molecules involved in local acute inflammatory response "	-Inf	1	"Cells and molecules involved in local acute inflammatory response "	""	0
"Selective expression of chemokine receptors during T cell polarization"	0.590883106040136	0.345475973621814	"Selective expression of chemokine receptors during T cell polarization"	"1437"	1
"IL 10 anti inflammatory signaling pathway "	-Inf	1	"IL 10 anti inflammatory signaling pathway "	""	0
"Signal transduction through IL1R"	0.719207203015675	0.372690244782872	"Signal transduction through IL1R"	"3551"	1
"G1 to S cell cycle control"	-Inf	1	"G1 to S cell cycle control"	""	0
"Cysteine and methionine catabolism"	-Inf	1	"Cysteine and methionine catabolism"	""	0
"Tyrosine metabolism and related disorders"	-Inf	1	"Tyrosine metabolism and related disorders"	""	0
"Molybdenum cofactor Moco biosynthesis"	-Inf	1	"Molybdenum cofactor Moco biosynthesis"	""	0
"Gamma glutamyl cycle for the biosynthesis and degradation of glutathione including diseases"	-Inf	1	"Gamma glutamyl cycle for the biosynthesis and degradation of glutathione including diseases"	""	0
"Cerebral organic acidurias including diseases"	-Inf	1	"Cerebral organic acidurias including diseases"	""	0
"Glycosylation and related congenital defects"	-Inf	1	"Glycosylation and related congenital defects"	""	0
"Metabolic pathway of LDL HDL and TG including diseases"	-Inf	1	"Metabolic pathway of LDL HDL and TG including diseases"	""	0
"Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism"	-Inf	1	"Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism"	""	0
"Alternative pathway of fetal androgen synthesis"	-Inf	1	"Alternative pathway of fetal androgen synthesis"	""	0
"Inflammatory response pathway"	-Inf	1	"Inflammatory response pathway"	""	0
"Intraflagellar transport proteins binding to dynein"	1.10107783835932	0.317091425552516	"Intraflagellar transport proteins binding to dynein"	"11020"	1
"Transcription co factors SKI and SKIL protein partners"	-Inf	1	"Transcription co factors SKI and SKIL protein partners"	""	0
"Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms"	-Inf	1	"Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms"	""	0
"Envelope proteins and their potential roles in EDMD physiopathology"	-0.00427516178690877	0.478224317638828	"Envelope proteins and their potential roles in EDMD physiopathology"	"23353"	1
"Genes related to primary cilium development based on CRISPR "	-0.541028569465445	1	"Genes related to primary cilium development based on CRISPR "	"11020"	1
"Hippo YAP signaling"	1.44503223957668	0.267046802285052	"Hippo YAP signaling"	"23043"	1
"Regulatory circuits of the STAT3 signaling pathway"	0.026530884994266	0.298547053072962	"Regulatory circuits of the STAT3 signaling pathway"	"10401;5600"	2
"Synaptic signaling pathways associated with autism spectrum disorder"	-Inf	1	"Synaptic signaling pathways associated with autism spectrum disorder"	""	0
"Hippo signaling regulation pathways"	-Inf	0.649298882387875	"Hippo signaling regulation pathways"	""	0
"Hippo Merlin signaling dysregulation"	-Inf	0.419437534326914	"Hippo Merlin signaling dysregulation"	""	0
"Leukocyte intrinsic Hippo pathway functions"	-Inf	1	"Leukocyte intrinsic Hippo pathway functions"	""	0
"Oxysterols derived from cholesterol"	-Inf	1	"Oxysterols derived from cholesterol"	""	0
"Fragile X syndrome"	-Inf	0.420633640398691	"Fragile X syndrome"	""	0
"GPCRs class A rhodopsin like"	-Inf	0.0536601495157879	"GPCRs class A rhodopsin like"	""	0
"FBXL10 enhancement of MAP ERK signaling in diffuse large B cell lymphoma"	-Inf	1	"FBXL10 enhancement of MAP ERK signaling in diffuse large B cell lymphoma"	""	0
"Overview of interferons mediated signaling pathway"	-Inf	1	"Overview of interferons mediated signaling pathway"	""	0
"Interactions between immune cells and microRNAs in tumor microenvironment"	0.312581943553032	0.485571531720117	"Interactions between immune cells and microRNAs in tumor microenvironment"	"10401"	1
"MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement"	-Inf	1	"MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement"	""	0
"Cell migration and invasion through p75NTR"	-Inf	1	"Cell migration and invasion through p75NTR"	""	0
"Canonical NF kB pathway"	1.97554695627546	0.106740666721343	"Canonical NF kB pathway"	"3551"	1
"Neural crest cell migration during development"	-Inf	1	"Neural crest cell migration during development"	""	0
"Neural crest cell migration in cancer"	-Inf	1	"Neural crest cell migration in cancer"	""	0
"Translation inhibitors in chronically activated PDGFRA cells"	-Inf	1	"Translation inhibitors in chronically activated PDGFRA cells"	""	0
"Urea cycle and related diseases"	-Inf	1	"Urea cycle and related diseases"	""	0
"Neurodegeneration with brain iron accumulation NBIA subtypes pathway"	-Inf	1	"Neurodegeneration with brain iron accumulation NBIA subtypes pathway"	""	0
"Cancer immunotherapy by CTLA4 blockade"	-Inf	1	"Cancer immunotherapy by CTLA4 blockade"	""	0
"Biomarkers for urea cycle disorders"	-Inf	1	"Biomarkers for urea cycle disorders"	""	0
"Biomarkers for pyrimidine metabolism disorders"	-Inf	1	"Biomarkers for pyrimidine metabolism disorders"	""	0
"Cancer immunotherapy by PD 1 blockade"	-Inf	1	"Cancer immunotherapy by PD 1 blockade"	""	0
"Metabolism of alpha linolenic acid"	-Inf	1	"Metabolism of alpha linolenic acid"	""	0
"Major receptors targeted by epinephrine and norepinephrine"	-Inf	1	"Major receptors targeted by epinephrine and norepinephrine"	""	0
"Urea cycle and associated pathways"	-Inf	1	"Urea cycle and associated pathways"	""	0
"Aerobic glycolysis"	-Inf	1	"Aerobic glycolysis"	""	0
"Measles virus infection"	-0.15830879045933	0.716058955814965	"Measles virus infection"	"81607;3551"	2
"Tryptophan metabolism"	-Inf	1	"Tryptophan metabolism"	""	0
"Cytosolic DNA sensing pathway"	-0.229567473629152	1	"Cytosolic DNA sensing pathway"	"3551"	1
"Joubert syndrome"	0.653618861388099	0.288150903125146	"Joubert syndrome"	"51199;22897"	2
"22q11 2 copy number variation syndrome"	-Inf	0.424491376052893	"22q11 2 copy number variation syndrome"	""	0
"Small cell lung cancer"	0.458971430534555	0.390362023880577	"Small cell lung cancer"	"7186;3551"	2
"Gastrin signaling pathway"	-0.983811059227193	1	"Gastrin signaling pathway"	"3551"	1
"DNA replication"	-Inf	1	"DNA replication"	""	0
"Amino acid metabolism pathway excerpt histidine catabolism extension"	-Inf	1	"Amino acid metabolism pathway excerpt histidine catabolism extension"	""	0
"Hepatitis B infection"	-0.56877355994835	1	"Hepatitis B infection"	"5600;3551"	2
"Male infertility"	-0.385909502798539	1	"Male infertility"	"27030;9985"	2
"Head and neck squamous cell carcinoma"	-Inf	0.62829594280072	"Head and neck squamous cell carcinoma"	""	0
"Melanoma"	-Inf	1	"Melanoma"	""	0
"Leucine isoleucine and valine metabolism"	-Inf	1	"Leucine isoleucine and valine metabolism"	""	0
"Serine metabolism"	-Inf	1	"Serine metabolism"	""	0
"Vitamin D sensitive calcium signaling in depression"	0.590883106040136	0.40723794475413	"Vitamin D sensitive calcium signaling in depression"	"23135"	1
"Pathways of nucleic acid metabolism and innate immune sensing"	-Inf	1	"Pathways of nucleic acid metabolism and innate immune sensing"	""	0
"Cholesterol metabolism with Bloch and Kandutsch Russell pathways"	-Inf	1	"Cholesterol metabolism with Bloch and Kandutsch Russell pathways"	""	0
"Eicosanoid metabolism via cyclooxygenases COX "	-Inf	1	"Eicosanoid metabolism via cyclooxygenases COX "	""	0
"Eicosanoid metabolism via cytochrome P450 monooxygenases pathway"	-Inf	1	"Eicosanoid metabolism via cytochrome P450 monooxygenases pathway"	""	0
"Eicosanoid metabolism via lipooxygenases LOX "	-Inf	1	"Eicosanoid metabolism via lipooxygenases LOX "	""	0
"Glycerolipids and glycerophospholipids"	-Inf	1	"Glycerolipids and glycerophospholipids"	""	0
"Omega 3 omega 6 fatty acid synthesis"	-Inf	1	"Omega 3 omega 6 fatty acid synthesis"	""	0
"Omega 9 fatty acid synthesis"	-Inf	1	"Omega 9 fatty acid synthesis"	""	0
"Sphingolipid metabolism overview"	-Inf	1	"Sphingolipid metabolism overview"	""	0
"Sphingolipid metabolism integrated pathway"	-Inf	1	"Sphingolipid metabolism integrated pathway"	""	0
"Endochondral ossification"	-Inf	1	"Endochondral ossification"	""	0
"Ketogenesis and ketolysis"	-Inf	1	"Ketogenesis and ketolysis"	""	0
"Thyroid hormones production and peripheral downstream signaling effects"	-Inf	0.642803694312354	"Thyroid hormones production and peripheral downstream signaling effects"	""	0
"Netrin UNC5B signaling pathway"	-Inf	1	"Netrin UNC5B signaling pathway"	""	0
"HIPK2 in kidney fibrosis"	-Inf	1	"HIPK2 in kidney fibrosis"	""	0
"Base excision repair"	-Inf	1	"Base excision repair"	""	0
"Nucleotide excision repair"	-Inf	1	"Nucleotide excision repair"	""	0
"IL 18 signaling pathway"	0.079382767260001	0.547245915320777	"IL 18 signaling pathway"	"3551"	1
"Renin angiotensin aldosterone system RAAS "	-Inf	1	"Renin angiotensin aldosterone system RAAS "	""	0
"Nephrotic syndrome"	-Inf	1	"Nephrotic syndrome"	""	0
"PKC gamma calcium signaling pathway in ataxia"	-Inf	1	"PKC gamma calcium signaling pathway in ataxia"	""	0
"FGFR3 signaling in chondrocyte proliferation and terminal differentiation"	1.2874909625902	0.317091425552516	"FGFR3 signaling in chondrocyte proliferation and terminal differentiation"	"5600"	1
"Cytoplasmic ribosomal proteins"	-Inf	0.637255177915644	"Cytoplasmic ribosomal proteins"	""	0
"Proteoglycan biosynthesis"	-Inf	1	"Proteoglycan biosynthesis"	""	0
"Somitogenesis in the context of spondylocostal dysostosis"	-Inf	1	"Somitogenesis in the context of spondylocostal dysostosis"	""	0
"Type I collagen synthesis in the context of osteogenesis imperfecta"	-Inf	1	"Type I collagen synthesis in the context of osteogenesis imperfecta"	""	0
"Osteoblast differentiation and related diseases"	-1.15830879045933	1	"Osteoblast differentiation and related diseases"	"5600"	1
"Autosomal recessive osteopetrosis pathways"	2.68604033908048	0.143786337822337	"Autosomal recessive osteopetrosis pathways"	"3551"	1
"Multiple epiphyseal dysplasia and pseudoachondroplasia genes"	-Inf	1	"Multiple epiphyseal dysplasia and pseudoachondroplasia genes"	""	0
"FGF23 signaling in hypophosphatemic rickets and related disorders"	1.33811703566017	0.277338416506654	"FGF23 signaling in hypophosphatemic rickets and related disorders"	"142680"	1
"Purine metabolism"	-Inf	1	"Purine metabolism"	""	0
"Downregulation of ACE2 by SARS CoV 2 spike protein"	-Inf	1	"Downregulation of ACE2 by SARS CoV 2 spike protein"	""	0
"Ciliopathies"	-0.235349826223158	0.744691104319889	"Ciliopathies"	"11020;374654;22897"	3
"Cholesterol biosynthesis with skeletal dysplasias"	-Inf	1	"Cholesterol biosynthesis with skeletal dysplasias"	""	0
"EGFR tyrosine kinase inhibitor resistance"	-Inf	0.633612846846397	"EGFR tyrosine kinase inhibitor resistance"	""	0
"Endochondral ossification with skeletal dysplasias"	-Inf	1	"Endochondral ossification with skeletal dysplasias"	""	0
"Insulin signaling"	-0.203256196513304	1	"Insulin signaling"	"5600;3551"	2
"Somatic sex determination"	-Inf	1	"Somatic sex determination"	""	0
"Glycosaminoglycan degradation"	-Inf	1	"Glycosaminoglycan degradation"	""	0
"TGF beta receptor signaling in skeletal dysplasias"	-Inf	1	"TGF beta receptor signaling in skeletal dysplasias"	""	0
"Conversion of angiotensinogen to angiotensin II "	-Inf	1	"Conversion of angiotensinogen to angiotensin II "	""	0
"Genes controlling nephrogenesis"	-Inf	1	"Genes controlling nephrogenesis"	""	0
"mBDNF and proBDNF regulation of GABA neurotransmission"	0.78791995309969	0.415575850732174	"mBDNF and proBDNF regulation of GABA neurotransmission"	"2564"	1
"GDNF RET signaling axis"	1.56050945699662	0.277338416506654	"GDNF RET signaling axis"	"11020"	1
"Regucalcin in proximal tubule epithelial kidney cells"	-Inf	1	"Regucalcin in proximal tubule epithelial kidney cells"	""	0
"Mammalian disorder of sexual development"	1.14547195771777	0.29749369331376	"Mammalian disorder of sexual development"	"5600"	1
"Influence of laminopathies on Wnt signaling"	-Inf	1	"Influence of laminopathies on Wnt signaling"	""	0
"SARS CoV 2 and COVID 19 pathway"	-Inf	1	"SARS CoV 2 and COVID 19 pathway"	""	0
"Linoleic acid metabolism affected by SARS CoV 2"	-Inf	1	"Linoleic acid metabolism affected by SARS CoV 2"	""	0
"Intracellular trafficking proteins involved in CMT neuropathy"	0.936018592088824	0.317091425552516	"Intracellular trafficking proteins involved in CMT neuropathy"	"90678"	1
"Hijack of ubiquitination by SARS CoV 2"	-Inf	1	"Hijack of ubiquitination by SARS CoV 2"	""	0
"Endoplasmic reticulum stress response in coronavirus infection"	-Inf	1	"Endoplasmic reticulum stress response in coronavirus infection"	""	0
"Host pathogen interaction of human coronaviruses autophagy"	-Inf	1	"Host pathogen interaction of human coronaviruses autophagy"	""	0
"Host pathogen interaction of human coronaviruses apoptosis"	1.62191000166076	0.267046802285052	"Host pathogen interaction of human coronaviruses apoptosis"	"5600"	1
"Type I interferon induction and signaling during SARS CoV 2 infection"	-Inf	1	"Type I interferon induction and signaling during SARS CoV 2 infection"	""	0
"Kisspeptin kisspeptin receptor system in the ovary"	-Inf	1	"Kisspeptin kisspeptin receptor system in the ovary"	""	0
"MAP3K1 role in promoting and blocking gonadal determination"	1.33811703566017	0.213367872561349	"MAP3K1 role in promoting and blocking gonadal determination"	"5600"	1
"Peroxiredoxin 2 induced ovarian failure"	-Inf	1	"Peroxiredoxin 2 induced ovarian failure"	""	0
"CAMKK2 pathway"	0.975546956275461	0.372690244782872	"CAMKK2 pathway"	"8874"	1
"Disruption of postsynaptic signaling by CNV"	-Inf	1	"Disruption of postsynaptic signaling by CNV"	""	0
"Activation of NLRP3 inflammasome by SARS CoV 2"	-Inf	1	"Activation of NLRP3 inflammasome by SARS CoV 2"	""	0
"Host pathogen interaction of human coronaviruses MAPK signaling"	0.753154534939013	0.398782096687208	"Host pathogen interaction of human coronaviruses MAPK signaling"	"5600"	1
"Overlap between signal transduction pathways contributing to LMNA laminopathies"	-Inf	1	"Overlap between signal transduction pathways contributing to LMNA laminopathies"	""	0
"Host pathogen interaction of human coronaviruses interferon induction"	1.10107783835932	0.372690244782872	"Host pathogen interaction of human coronaviruses interferon induction"	"3551"	1
"SARS CoV 2 and ACE2 receptor molecular mechanisms"	-Inf	1	"SARS CoV 2 and ACE2 receptor molecular mechanisms"	""	0
"Pathogenesis of SARS CoV 2 mediated by nsp9 nsp10 complex"	-Inf	1	"Pathogenesis of SARS CoV 2 mediated by nsp9 nsp10 complex"	""	0
"COVID 19 adverse outcome pathway"	-Inf	1	"COVID 19 adverse outcome pathway"	""	0
"IL 2 signaling pathway"	-Inf	1	"IL 2 signaling pathway"	""	0
"Purinergic signaling"	-Inf	1	"Purinergic signaling"	""	0
"LDLRAD4 and what we know about it"	-Inf	1	"LDLRAD4 and what we know about it"	""	0
"1q21 1 copy number variation syndrome"	-Inf	1	"1q21 1 copy number variation syndrome"	""	0
"3q29 copy number variation syndrome"	-Inf	1	"3q29 copy number variation syndrome"	""	0
"SARS coronavirus and innate immunity"	-Inf	1	"SARS coronavirus and innate immunity"	""	0
"Proximal tubule transport"	1.21473462015489	0.189805657021719	"Proximal tubule transport"	"65010;142680"	2
"Cellular proteostasis"	-Inf	1	"Cellular proteostasis"	""	0
"Neuroinflammation"	-Inf	1	"Neuroinflammation"	""	0
"Mitochondrial complex II assembly"	-Inf	1	"Mitochondrial complex II assembly"	""	0
"Mitochondrial complex III assembly"	-Inf	1	"Mitochondrial complex III assembly"	""	0
"Mitochondrial complex IV assembly"	-Inf	1	"Mitochondrial complex IV assembly"	""	0
"Autophagy"	-Inf	1	"Autophagy"	""	0
"Unfolded protein response"	-Inf	1	"Unfolded protein response"	""	0
"COVID 19 thrombosis and anticoagulation"	-Inf	1	"COVID 19 thrombosis and anticoagulation"	""	0
"MAPK pathway in congenital thyroid cancer"	-Inf	1	"MAPK pathway in congenital thyroid cancer"	""	0
"Direct reversal repair"	-Inf	1	"Direct reversal repair"	""	0
"7q11 23 copy number variation syndrome"	-Inf	0.408059505041595	"7q11 23 copy number variation syndrome"	""	0
"Perturbations to host cell autophagy induced by SARS CoV 2 proteins"	-Inf	1	"Perturbations to host cell autophagy induced by SARS CoV 2 proteins"	""	0
"15q11 2 copy number variation syndrome"	-Inf	1	"15q11 2 copy number variation syndrome"	""	0
"GPR143 in melanocytes and retinal pigment epithelium cells"	-Inf	1	"GPR143 in melanocytes and retinal pigment epithelium cells"	""	0
"15q13 3 copy number variation syndrome"	-Inf	1	"15q13 3 copy number variation syndrome"	""	0
"DNA repair pathways full network"	-Inf	0.418287994876429	"DNA repair pathways full network"	""	0
"Nitric oxide metabolism in cystic fibrosis"	2.44503223957668	0.167632895222882	"Nitric oxide metabolism in cystic fibrosis"	"3276"	1
"16p11 2 proximal deletion syndrome"	-0.229567473629152	1	"16p11 2 proximal deletion syndrome"	"7186"	1
"16p11 2 distal deletion syndrome"	1.97554695627546	0.0775254462281555	"16p11 2 distal deletion syndrome"	"3276;7186"	2
"Steroid biosynthesis"	-Inf	1	"Steroid biosynthesis"	""	0
"STING pathway in Kawasaki like disease and COVID 19"	1.14547195771777	0.256609871505098	"STING pathway in Kawasaki like disease and COVID 19"	"3551"	1
"Airway smooth muscle cell contraction"	-Inf	1	"Airway smooth muscle cell contraction"	""	0
"p53 transcriptional gene network"	-Inf	0.647931744488466	"p53 transcriptional gene network"	""	0
"Fluoroacetic acid toxicity"	-Inf	1	"Fluoroacetic acid toxicity"	""	0
"RAS and bradykinin pathways in COVID 19"	-Inf	1	"RAS and bradykinin pathways in COVID 19"	""	0
"Urea cycle and metabolism of amino groups"	-Inf	1	"Urea cycle and metabolism of amino groups"	""	0
"Galanin receptor pathway"	-Inf	1	"Galanin receptor pathway"	""	0
"Phosphoinositides metabolism"	-Inf	1	"Phosphoinositides metabolism"	""	0
"Glycogen synthesis and degradation"	-Inf	1	"Glycogen synthesis and degradation"	""	0
"GPCRs class C metabotropic glutamate pheromone"	-Inf	1	"GPCRs class C metabotropic glutamate pheromone"	""	0
"Proline and hydroxyproline pathways"	-Inf	1	"Proline and hydroxyproline pathways"	""	0
"nsp1 from SARS CoV 2 inhibits translation initiation in the host cell"	-Inf	1	"nsp1 from SARS CoV 2 inhibits translation initiation in the host cell"	""	0
"Glycine metabolism including IMDs"	-Inf	1	"Glycine metabolism including IMDs"	""	0
"Amino acid transport defects IEMs "	-Inf	1	"Amino acid transport defects IEMs "	""	0
"Ethylmalonic encephalopathy"	-Inf	1	"Ethylmalonic encephalopathy"	""	0
"Biotin metabolism including IMDs"	-Inf	1	"Biotin metabolism including IMDs"	""	0
"Genes associated with the development of rheumatoid arthritis"	-Inf	1	"Genes associated with the development of rheumatoid arthritis"	""	0
"Angiotensin II receptor type 1 pathway"	-Inf	1	"Angiotensin II receptor type 1 pathway"	""	0
"Riboflavin and CoQ disorders"	-Inf	1	"Riboflavin and CoQ disorders"	""	0
"Mitochondrial immune response to SARS CoV 2"	-Inf	1	"Mitochondrial immune response to SARS CoV 2"	""	0
"SARS CoV 2 innate immunity evasion and cell specific immune response"	1.40850636355157	0.0649144911955547	"SARS CoV 2 innate immunity evasion and cell specific immune response"	"1437;7020;7186"	3
"Pentose phosphate pathway in senescent cells"	-Inf	1	"Pentose phosphate pathway in senescent cells"	""	0
"Kynurenine pathway and links to cell senescence"	-Inf	1	"Kynurenine pathway and links to cell senescence"	""	0
"NAD metabolism in oncogene induced senescence and mitochondrial dysfunction associated senescence"	-Inf	1	"NAD metabolism in oncogene induced senescence and mitochondrial dysfunction associated senescence"	""	0
"Glycolysis in senescence"	-Inf	1	"Glycolysis in senescence"	""	0
"TCA cycle in senescence"	-Inf	1	"TCA cycle in senescence"	""	0
"Nephrogenesis"	-Inf	1	"Nephrogenesis"	""	0
"Development of ureteric collection system"	-Inf	1	"Development of ureteric collection system"	""	0
"Burn wound healing"	-Inf	0.6285505828186	"Burn wound healing"	""	0
"Fatty acid transporters"	-Inf	1	"Fatty acid transporters"	""	0
"FOXP3 in COVID 19"	-Inf	1	"FOXP3 in COVID 19"	""	0
"7 oxo C and 7 beta HC pathways"	-Inf	1	"7 oxo C and 7 beta HC pathways"	""	0
"SARS CoV 2 altering angiogenesis via NRP1"	-Inf	1	"SARS CoV 2 altering angiogenesis via NRP1"	""	0
"FOXA2 pathway"	-Inf	1	"FOXA2 pathway"	""	0
"Modulators of TCR signaling and T cell activation"	1.16819203421786	0.210251195476039	"Modulators of TCR signaling and T cell activation"	"7409;3551"	2
"Kallmann syndrome"	1.01618894077281	0.287486720546743	"Kallmann syndrome"	"55636"	1
"Soluble ACE2 mediated cell entry of SARS CoV 2"	-Inf	1	"Soluble ACE2 mediated cell entry of SARS CoV 2"	""	0
"T cell modulation in pancreatic cancer"	-Inf	1	"T cell modulation in pancreatic cancer"	""	0
"Neuroinflammation and glutamatergic signaling"	-Inf	0.269553846762716	"Neuroinflammation and glutamatergic signaling"	""	0
"Vasopressin regulated water reabsorption"	-Inf	1	"Vasopressin regulated water reabsorption"	""	0
"Pleural mesothelioma"	-1.46185835603184	0.291422374844332	"Pleural mesothelioma"	"23043;1437;7186"	3
"Prostaglandin signaling"	-Inf	1	"Prostaglandin signaling"	""	0
"Kinin Kallikrein pathway"	-Inf	1	"Kinin Kallikrein pathway"	""	0
"Complement system in neuronal development and plasticity"	-Inf	0.408059505041595	"Complement system in neuronal development and plasticity"	""	0
"Interactions of natural killer cells in pancreatic cancer"	0.753154534939013	0.326686008829877	"Interactions of natural killer cells in pancreatic cancer"	"1437"	1
"Opioid receptor pathways"	-Inf	1	"Opioid receptor pathways"	""	0
"Orexin receptor pathway"	-Inf	0.637255177915644	"Orexin receptor pathway"	""	0
"Overview of proinflammatory and profibrotic mediators"	-1.19437804516685	1	"Overview of proinflammatory and profibrotic mediators"	"1437"	1
"CCL18 signaling pathway"	-Inf	1	"CCL18 signaling pathway"	""	0
"T cell activation SARS CoV 2"	-0.74934580559017	1	"T cell activation SARS CoV 2"	"3551"	1
"Regulation of actin cytoskeleton"	0.408506363551567	0.469265776130742	"Regulation of actin cytoskeleton"	"8874;7409;9138"	3
"Congenital generalized lipodystrophy"	-Inf	1	"Congenital generalized lipodystrophy"	""	0
"Familial partial lipodystrophy"	-Inf	1	"Familial partial lipodystrophy"	""	0
"Progeria associated lipodystrophy"	-Inf	1	"Progeria associated lipodystrophy"	""	0
"Acquired partial lipodystrophy Barraquer Simons syndrome"	-Inf	1	"Acquired partial lipodystrophy Barraquer Simons syndrome"	""	0
"Familial hyperlipidemia type 1"	-Inf	1	"Familial hyperlipidemia type 1"	""	0
"Familial hyperlipidemia type 2"	-Inf	1	"Familial hyperlipidemia type 2"	""	0
"Familial hyperlipidemia type 3"	-Inf	1	"Familial hyperlipidemia type 3"	""	0
"Familial hyperlipidemia type 4"	-Inf	1	"Familial hyperlipidemia type 4"	""	0
"Familial hyperlipidemia type 5"	-Inf	1	"Familial hyperlipidemia type 5"	""	0
"Antiviral and anti inflammatory effects of Nrf2 on SARS CoV 2 pathway"	0.78791995309969	0.36374585694788	"Antiviral and anti inflammatory effects of Nrf2 on SARS CoV 2 pathway"	"3551"	1
"Nucleotide excision repair in xeroderma pigmentosum "	-Inf	0.6285505828186	"Nucleotide excision repair in xeroderma pigmentosum "	""	0
"Network map of SARS CoV 2 signaling pathway"	-2.01439937906062	0.375889175287631	"Network map of SARS CoV 2 signaling pathway"	"7186"	1
"SARS CoV 2 B 1 1 7 variant antagonises innate immune activation"	-Inf	1	"SARS CoV 2 B 1 1 7 variant antagonises innate immune activation"	""	0
"Cohesin complex Cornelia de Lange syndrome"	-0.773391279556821	0.381509935339445	"Cohesin complex Cornelia de Lange syndrome"	"9985"	1
"SMC1 SMC3 role in DNA damage Cornelia de Lange Syndrome"	-Inf	1	"SMC1 SMC3 role in DNA damage Cornelia de Lange Syndrome"	""	0
"NIPBL role in DNA damage Cornelia de Lange syndrome"	-Inf	1	"NIPBL role in DNA damage Cornelia de Lange syndrome"	""	0
"Inclusion body myositis"	-Inf	1	"Inclusion body myositis"	""	0
"Sphingolipid metabolism in senescence"	-Inf	1	"Sphingolipid metabolism in senescence"	""	0
"Prostaglandin and leukotriene metabolism in senescence "	-0.194378045166852	0.381509935339445	"Prostaglandin and leukotriene metabolism in senescence "	"5600"	1
"Mitochondrial fatty acid oxidation disorders"	-Inf	1	"Mitochondrial fatty acid oxidation disorders"	""	0
"Alzheimer 39 s disease"	-1.07369656274439	0.589844468025615	"Alzheimer 39 s disease"	"7186;3551"	2
"Th17 cell differentiation pathway"	0.575616349386825	0.256900148555147	"Th17 cell differentiation pathway"	"5187;3551"	2
"Non classical role of vitamin D"	-Inf	1	"Non classical role of vitamin D"	""	0
"ALA oxylipin metabolism"	-Inf	1	"ALA oxylipin metabolism"	""	0
"Linoleic acid oxylipin metabolism"	-Inf	1	"Linoleic acid oxylipin metabolism"	""	0
"Calcium mediated T cell apoptosis involved in inclusion body myositis"	-Inf	1	"Calcium mediated T cell apoptosis involved in inclusion body myositis"	""	0
"GDNF signaling"	-Inf	1	"GDNF signaling"	""	0
"NRP1 triggered signaling pathways in pancreatic cancer "	-Inf	1	"NRP1 triggered signaling pathways in pancreatic cancer "	""	0
"COVID 19 structural coverage map"	1.44503223957668	0.307361286620613	"COVID 19 structural coverage map"	"3508"	1
"Lung pathology of COVID 19"	1.68604033908048	0.246025589943613	"Lung pathology of COVID 19"	"1437"	1
"Complement mediated inflammation of pulmonary alveolus in COVID 19 hypothetical pathway "	-Inf	1	"Complement mediated inflammation of pulmonary alveolus in COVID 19 hypothetical pathway "	""	0
"Lipid metabolism in senescent cells"	-Inf	1	"Lipid metabolism in senescent cells"	""	0
"Spina bifida"	-Inf	1	"Spina bifida"	""	0
"Iron sulfur cluster biogenesis"	-Inf	1	"Iron sulfur cluster biogenesis"	""	0
"N glycan biosynthesis"	-Inf	1	"N glycan biosynthesis"	""	0
"Docosahexaenoic acid oxylipin metabolism"	-Inf	1	"Docosahexaenoic acid oxylipin metabolism"	""	0
"Arachidonic acid AA ARA oxylipin metabolism"	-Inf	1	"Arachidonic acid AA ARA oxylipin metabolism"	""	0
"SARS CoV 2 replication organelle formation"	-Inf	1	"SARS CoV 2 replication organelle formation"	""	0
"Urotensin II mediated signaling pathway"	-0.785265379845113	0.623604450509212	"Urotensin II mediated signaling pathway"	"3551"	1
"Hypertrophy model"	-Inf	1	"Hypertrophy model"	""	0
"Glyoxylate metabolism"	-Inf	1	"Glyoxylate metabolism"	""	0
"Hemesynthesis defects and porphyrias"	-Inf	1	"Hemesynthesis defects and porphyrias"	""	0
"Leukotriene metabolic pathway"	-Inf	1	"Leukotriene metabolic pathway"	""	0
"Iron metabolism disorders"	-Inf	1	"Iron metabolism disorders"	""	0
"Disorders of galactose metabolism "	-Inf	1	"Disorders of galactose metabolism "	""	0
"Ulcerative colitis signaling"	-Inf	1	"Ulcerative colitis signaling"	""	0
"Disorders in ketone body synthesis"	-Inf	1	"Disorders in ketone body synthesis"	""	0
"Disorders of bile acid synthesis and biliary transport"	-Inf	1	"Disorders of bile acid synthesis and biliary transport"	""	0
"Disorders of fructose metabolism"	-Inf	1	"Disorders of fructose metabolism"	""	0
"Biosynthesis and turnover of 1 deoxy sphingoid bases"	-Inf	1	"Biosynthesis and turnover of 1 deoxy sphingoid bases"	""	0
"DYRK1A involvement regarding cell proliferation in brain development"	-Inf	0.999999999999999	"DYRK1A involvement regarding cell proliferation in brain development"	""	0
"Roles of ceramides in development of insulin resistance"	-Inf	1	"Roles of ceramides in development of insulin resistance"	""	0
"Pro survival signaling of neuroprotectin D1"	1.50161576794305	0.190820724646225	"Pro survival signaling of neuroprotectin D1"	"7186"	1
"SARS CoV 2 mitochondrial chronic oxidative stress and endothelial dysfunction"	-Inf	1	"SARS CoV 2 mitochondrial chronic oxidative stress and endothelial dysfunction"	""	0
"Vitamin K metabolism and activation of dependent proteins"	-Inf	1	"Vitamin K metabolism and activation of dependent proteins"	""	0
"mRNA vaccine activation of dendritic cell and induction of IFN 1"	-Inf	1	"mRNA vaccine activation of dendritic cell and induction of IFN 1"	""	0
"Copper metabolism"	-Inf	1	"Copper metabolism"	""	0
"Creatine pathway"	-Inf	1	"Creatine pathway"	""	0
"Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution"	-Inf	1	"Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution"	""	0
"Modulation of PI3K Akt mTOR signaling by bioactive sphingolipids"	-Inf	1	"Modulation of PI3K Akt mTOR signaling by bioactive sphingolipids"	""	0
"Cholesterol synthesis disorders"	-Inf	1	"Cholesterol synthesis disorders"	""	0
"Synthesis of ceramides and 1 deoxyceramides"	-Inf	1	"Synthesis of ceramides and 1 deoxyceramides"	""	0
"Disorders in ketolysis"	-Inf	1	"Disorders in ketolysis"	""	0
"Inflammatory bowel disease signaling"	-Inf	1	"Inflammatory bowel disease signaling"	""	0
"PtdIns 4 5 P2 in cytokinesis pathway"	-Inf	1	"PtdIns 4 5 P2 in cytokinesis pathway"	""	0
"Dravet syndrome"	1.14547195771777	0.326686008829877	"Dravet syndrome"	"5600"	1
"Alstrom syndrome"	0.823543862830411	0.381509935339445	"Alstrom syndrome"	"11020"	1
"Clock controlled autophagy in bone metabolism"	-0.512739525034021	1	"Clock controlled autophagy in bone metabolism"	"5187"	1
"Amino acid conjugation of benzoic acid"	-Inf	1	"Amino acid conjugation of benzoic acid"	""	0
"Glucose metabolism in triple negative breast cancer cells"	-Inf	1	"Glucose metabolism in triple negative breast cancer cells"	""	0
"Amino acid metabolism in triple negative breast cancer cells"	-Inf	1	"Amino acid metabolism in triple negative breast cancer cells"	""	0
"Warburg effect modulated by deubiquitinating enzymes and their substrates"	-Inf	1	"Warburg effect modulated by deubiquitinating enzymes and their substrates"	""	0
"Extrafollicular and follicular B cell activation by SARS CoV 2"	-Inf	0.628871664718039	"Extrafollicular and follicular B cell activation by SARS CoV 2"	""	0
"Diet dependent trimethylamine trimethylamine N oxide metabolism "	-Inf	1	"Diet dependent trimethylamine trimethylamine N oxide metabolism "	""	0
"Metabolic reprogramming in pancreatic cancer"	-Inf	1	"Metabolic reprogramming in pancreatic cancer"	""	0
"2q11 2 copy number variation syndrome"	-Inf	1	"2q11 2 copy number variation syndrome"	""	0
"2q13 copy number variation syndrome"	-0.0833467327781077	0.59009463983586	"2q13 copy number variation syndrome"	"1437"	1
"2q21 1 copy number variation syndrome"	-Inf	1	"2q21 1 copy number variation syndrome"	""	0
"2q37 copy number variation syndrome"	-1.23823233475628	0.725194721768233	"2q37 copy number variation syndrome"	"8527"	1
"Nephrotoxcicity adverse outcome pathway"	-Inf	1	"Nephrotoxcicity adverse outcome pathway"	""	0
"Hippocampal synaptogenesis and neurogenesis"	-Inf	1	"Hippocampal synaptogenesis and neurogenesis"	""	0
"Arsenic metabolism and reactive oxygen species generation"	-Inf	1	"Arsenic metabolism and reactive oxygen species generation"	""	0
"Bardet Biedl syndrome"	1.23858136210925	0.125509031813838	"Bardet Biedl syndrome"	"11020;374654;22897"	3
"Estradiol regulation in porto sinusoidal vascular disease"	-Inf	1	"Estradiol regulation in porto sinusoidal vascular disease"	""	0
"Markers of kidney cell lineage"	-Inf	1	"Markers of kidney cell lineage"	""	0
"Cholestasis"	-Inf	1	"Cholestasis"	""	0
"Lac Phe pathway"	-Inf	1	"Lac Phe pathway"	""	0
"G13 signaling pathway"	0.860069738855525	0.423797445928164	"G13 signaling pathway"	"9138"	1
"Mitochondrial beta oxidation"	-Inf	1	"Mitochondrial beta oxidation"	""	0
"COVID 19 and endothelial cell senescence"	-Inf	1	"COVID 19 and endothelial cell senescence"	""	0
"Role of ROS in COVID 19 endothelial dysfunction"	-Inf	1	"Role of ROS in COVID 19 endothelial dysfunction"	""	0
"Genetic causes of porto sinusoidal vascular disease"	-Inf	1	"Genetic causes of porto sinusoidal vascular disease"	""	0
"LDL influence on CD14 and TLR4"	1.01618894077281	0.277338416506654	"LDL influence on CD14 and TLR4"	"5600"	1
"Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists"	-Inf	1	"Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists"	""	0
"Ether lipid biosynthesis"	1.68604033908048	0.246025589943613	"Ether lipid biosynthesis"	"5189"	1
"Estrogen metabolism"	-Inf	1	"Estrogen metabolism"	""	0
"Steroid hormone precursor biosynthesis"	-Inf	1	"Steroid hormone precursor biosynthesis"	""	0
"Mineralocorticoid biosynthesis"	-Inf	1	"Mineralocorticoid biosynthesis"	""	0
"Acetylcholine synthesis"	-Inf	1	"Acetylcholine synthesis"	""	0
"Glucocorticoid biosynthesis"	-Inf	1	"Glucocorticoid biosynthesis"	""	0
"Chronic hyperglycemia impairment of neuron function"	-Inf	1	"Chronic hyperglycemia impairment of neuron function"	""	0
"Cell interactions of the pancreatic cancer microenvironment"	1.14547195771777	0.307361286620613	"Cell interactions of the pancreatic cancer microenvironment"	"1437"	1
"Immune infiltration in pancreatic cancer"	-0.121314582977128	0.423797445928164	"Immune infiltration in pancreatic cancer"	"1437"	1
"17q12 copy number variation syndrome"	-Inf	0.406714728223729	"17q12 copy number variation syndrome"	""	0
"Glycosphingolipid metabolism"	-Inf	1	"Glycosphingolipid metabolism"	""	0
"Acute myeloid leukemia"	0.878685417022872	0.251693035723549	"Acute myeloid leukemia"	"1437;3551"	2
"Sildenafil treatment"	-Inf	1	"Sildenafil treatment"	""	0
"Ganglio series sphingolipid metabolism"	-Inf	1	"Ganglio series sphingolipid metabolism"	""	0
"ID signaling pathway"	-Inf	1	"ID signaling pathway"	""	0
"Cytokines and inflammatory response"	0.0369475009396044	0.307361286620613	"Cytokines and inflammatory response"	"1437"	1
"TROP2 regulatory signaling"	-Inf	1	"TROP2 regulatory signaling"	""	0
"Lacto series sphingolipid metabolism"	-Inf	1	"Lacto series sphingolipid metabolism"	""	0
"Cholesterol metabolism"	-Inf	0.627993773769284	"Cholesterol metabolism"	""	0
"DNA mismatch repair"	-Inf	1	"DNA mismatch repair"	""	0
"Isoglobo series sphingolipids"	-Inf	1	"Isoglobo series sphingolipids"	""	0
"Metabolic pathways of fibroblasts"	-Inf	1	"Metabolic pathways of fibroblasts"	""	0
"Carnosine metabolism of glial cells"	-Inf	1	"Carnosine metabolism of glial cells"	""	0
"Lactate shuttle in glial cells"	-Inf	1	"Lactate shuttle in glial cells"	""	0
"Sebaleic acid formation and metabolism"	-Inf	1	"Sebaleic acid formation and metabolism"	""	0
"Primary ovarian insufficiency"	-Inf	0.180808873521598	"Primary ovarian insufficiency"	""	0
"Female steroid hormones in cardiomyocyte energy metabolism"	-Inf	1	"Female steroid hormones in cardiomyocyte energy metabolism"	""	0
"Male steroid hormones in cardiomyocyte energy metabolism"	-Inf	1	"Male steroid hormones in cardiomyocyte energy metabolism"	""	0
"Fatty acids and lipoproteins transport in hepatocytes"	-Inf	1	"Fatty acids and lipoproteins transport in hepatocytes"	""	0
"Octadecanoid formation from linoleic acid"	-Inf	1	"Octadecanoid formation from linoleic acid"	""	0
"Cholesterol biosynthesis pathway in hepatocytes"	-Inf	1	"Cholesterol biosynthesis pathway in hepatocytes"	""	0
"Autophagy in pancreatic ductal adenocarcinoma"	-Inf	1	"Autophagy in pancreatic ductal adenocarcinoma"	""	0
"Enterocyte cholesterol metabolism"	-Inf	1	"Enterocyte cholesterol metabolism"	""	0
"Induction of autophagy and toll like receptor signaling pathways by graphene oxide "	-Inf	1	"Induction of autophagy and toll like receptor signaling pathways by graphene oxide "	""	0
"Glycolysis and gluconeogenesis"	-Inf	1	"Glycolysis and gluconeogenesis"	""	0
"Pathophysiological roles of DUX4 in FSHD1"	-Inf	1	"Pathophysiological roles of DUX4 in FSHD1"	""	0
"Abnormal calcium handling and its effects on muscle contraction in DMD"	-Inf	1	"Abnormal calcium handling and its effects on muscle contraction in DMD"	""	0
"Cardiomyocyte signaling pathways converging on titin"	-Inf	1	"Cardiomyocyte signaling pathways converging on titin"	""	0
"1p36 copy number variation syndrome"	1.07222297568713	0.147941508382594	"1p36 copy number variation syndrome"	"8764;339451;7186"	3
"8p23 1 copy number variation syndrome"	-Inf	1	"8p23 1 copy number variation syndrome"	""	0
"IL 26 signaling pathways"	0.123104144689319	0.492816145652106	"IL 26 signaling pathways"	"1437"	1
"11p11 2 copy number variation syndrome "	0.238581362109255	0.547245915320777	"11p11 2 copy number variation syndrome "	"84680"	1
"Kleefstra syndrome"	-Inf	1	"Kleefstra syndrome"	""	0
"10q11 21q11 23 copy number variation syndrome"	-Inf	1	"10q11 21q11 23 copy number variation syndrome"	""	0
"Macrophage stimulating protein MSP signaling network map"	-1.49838423205695	1	"Macrophage stimulating protein MSP signaling network map"	"4486"	1
"Metabolic Epileptic Disorders"	-0.541028569465445	1	"Metabolic Epileptic Disorders"	"48"	1
"Affected pathways in Duchenne muscular dystrophy"	-Inf	0.62829594280072	"Affected pathways in Duchenne muscular dystrophy"	""	0
"JAK STAT signaling in the regulation of beta cells"	-Inf	1	"JAK STAT signaling in the regulation of beta cells"	""	0
"Calcium regulation in cardiac cells"	-Inf	0.279053274453371	"Calcium regulation in cardiac cells"	""	0
"KCNQ2 related epilepsies"	-Inf	1	"KCNQ2 related epilepsies"	""	0
"TAR syndrome"	1.54060989955891	0.0580287125566642	"TAR syndrome"	"8764;10401;142680"	3
"4p16 3 copy number variation"	-Inf	1	"4p16 3 copy number variation"	""	0
"NF1 copy number variation syndrome "	-1.05420038711859	1	"NF1 copy number variation syndrome "	"5187"	1
"Rubinstein Taybi syndrome 1"	-Inf	1	"Rubinstein Taybi syndrome 1"	""	0
"Sulfatase and aromatase pathway"	-Inf	1	"Sulfatase and aromatase pathway"	""	0
"Involvement of secretase in neurodegenerative diseases"	-Inf	1	"Involvement of secretase in neurodegenerative diseases"	""	0
"Osteoarthritic chondrocyte hypertrophy"	-Inf	1	"Osteoarthritic chondrocyte hypertrophy"	""	0
"17p13 3 YWHAE copy number variation"	-Inf	1	"17p13 3 YWHAE copy number variation"	""	0
"5q35 copy number variation"	-0.820312326944314	1	"5q35 copy number variation"	"23135"	1
"Smith Magenis and Potocki Lupski syndrome copy number variation"	-0.469237886397435	1	"Smith Magenis and Potocki Lupski syndrome copy number variation"	"11020;5187"	2
"TGF Smad signaling pathway"	-Inf	1	"TGF Smad signaling pathway"	""	0
"Growth factors and hormones in beta cell proliferation"	-Inf	1	"Growth factors and hormones in beta cell proliferation"	""	0
"Pancreatic cancer subtypes"	-Inf	1	"Pancreatic cancer subtypes"	""	0
"UDP derived sugars synthesis in fibroblasts"	-Inf	1	"UDP derived sugars synthesis in fibroblasts"	""	0
"Glycosaminoglycan synthesis in fibroblasts"	-Inf	1	"Glycosaminoglycan synthesis in fibroblasts"	""	0
"Enterohepatic circulation of bile acids"	-Inf	1	"Enterohepatic circulation of bile acids"	""	0
"Vitamin A1 and A5 X pathways"	-Inf	1	"Vitamin A1 and A5 X pathways"	""	0
"NRXN1 deletion syndrome"	-Inf	1	"NRXN1 deletion syndrome"	""	0
"NPHP1 deletion syndrome"	-Inf	1	"NPHP1 deletion syndrome"	""	0
"6q16 copy number variation"	-Inf	1	"6q16 copy number variation"	""	0
"7q11 23 distal copy number variation"	-Inf	1	"7q11 23 distal copy number variation"	""	0
"10q22q23 copy number variation"	-Inf	1	"10q22q23 copy number variation"	""	0
"13q12 or CRYL1 copy number variation "	-Inf	1	"13q12 or CRYL1 copy number variation "	""	0
"13q12 12 copy number variation"	1.01618894077281	0.381509935339445	"13q12 12 copy number variation"	"7186"	1
"15q11q13 copy number variation"	-Inf	1	"15q11q13 copy number variation"	""	0
"15q25 copy number variation"	-Inf	1	"15q25 copy number variation"	""	0
"PAFAH1B1 copy number variation"	-Inf	1	"PAFAH1B1 copy number variation"	""	0
"Phosphatidyl inositol phosphate pathway"	-Inf	1	"Phosphatidyl inositol phosphate pathway"	""	0
"8q11 23 RB1CC1 copy number variation"	1.97554695627546	0.20217327519646	"8q11 23 RB1CC1 copy number variation"	"7186"	1
"IDO metabolic pathway"	-Inf	1	"IDO metabolic pathway"	""	0
"Cell lineage map for neuronal differentiation"	-Inf	0.266933141501158	"Cell lineage map for neuronal differentiation"	""	0
"ADHD and autism ASD linked metabolic pathways and SNP"	-2.54102856946544	0.0656407315118946	"ADHD and autism ASD linked metabolic pathways and SNP"	"5826"	1
"IL 19 signaling pathway"	-Inf	1	"IL 19 signaling pathway"	""	0
"Omega 6 fatty acids in senescence"	-0.246845465060987	0.485571531720117	"Omega 6 fatty acids in senescence"	"5600"	1
"HDAC6 interactions in the central nervous system"	-Inf	0.410892387290647	"HDAC6 interactions in the central nervous system"	""	0
"FGFR4 p G388R signaling pathway"	-Inf	1	"FGFR4 p G388R signaling pathway"	""	0
"FLT3 p Gln640SerfsTer8 signaling pathway"	-Inf	1	"FLT3 p Gln640SerfsTer8 signaling pathway"	""	0
"PGK1 PKM2 KHKC KHKA acting as protein kinases"	-Inf	1	"PGK1 PKM2 KHKC KHKA acting as protein kinases"	""	0
"Pathways in cancer"	-1.13761639530623	0.32662693161748	"Pathways in cancer"	"374654;9138;7186;3551"	4
"GNAQ pathways in port wine stain"	-Inf	1	"GNAQ pathways in port wine stain"	""	0
"EPAC1 and PKA reduction of retinal inflammation"	-Inf	1	"EPAC1 and PKA reduction of retinal inflammation"	""	0
"Artemisinin inhibition of uveal melanoma"	-Inf	1	"Artemisinin inhibition of uveal melanoma"	""	0
"Wnt Beta catenin signaling inhibitors in current and past clinical trials"	-Inf	1	"Wnt Beta catenin signaling inhibitors in current and past clinical trials"	""	0
"Acetaminophen in analgesia and antipyresis"	-Inf	1	"Acetaminophen in analgesia and antipyresis"	""	0
"Hunger and satiety"	-Inf	1	"Hunger and satiety"	""	0
"Complement activation"	-Inf	1	"Complement activation"	""	0
"Biogenic amine synthesis"	-Inf	1	"Biogenic amine synthesis"	""	0
"ACE inhibitor pathway"	-Inf	1	"ACE inhibitor pathway"	""	0
"Complement and coagulation cascades"	-Inf	1	"Complement and coagulation cascades"	""	0
"TGF beta receptor signaling"	-Inf	1	"TGF beta receptor signaling"	""	0
"Heme biosynthesis"	-Inf	1	"Heme biosynthesis"	""	0
"Monoamine GPCRs"	-Inf	1	"Monoamine GPCRs"	""	0
"EPO receptor signaling"	-Inf	1	"EPO receptor signaling"	""	0
"Interferon type I signaling pathways"	1.62191000166076	0.0396327562943023	"Interferon type I signaling pathways"	"10401;7409;3276"	3
"Notch signaling pathway"	-Inf	1	"Notch signaling pathway"	""	0
"Type II interferon signaling"	-Inf	1	"Type II interferon signaling"	""	0
"Oxidative phosphorylation"	-Inf	1	"Oxidative phosphorylation"	""	0
"Glucose homeostasis"	-Inf	1	"Glucose homeostasis"	""	0
"ErbB signaling pathway"	-Inf	0.639350404519374	"ErbB signaling pathway"	""	0
"Arachidonate epoxygenase epoxide hydrolase"	-Inf	1	"Arachidonate epoxygenase epoxide hydrolase"	""	0
"Catalytic cycle of mammalian flavin containing monooxygenases FMOs "	-Inf	1	"Catalytic cycle of mammalian flavin containing monooxygenases FMOs "	""	0
"T cell receptor signaling pathway"	0.686040339080476	0.282946553656207	"T cell receptor signaling pathway"	"7409;3551"	2
"Polyol pathway"	-Inf	1	"Polyol pathway"	""	0
"Tamoxifen metabolism"	-Inf	1	"Tamoxifen metabolism"	""	0
"Sulfation biotransformation reaction"	-Inf	1	"Sulfation biotransformation reaction"	""	0
"Arylamine metabolism"	-Inf	1	"Arylamine metabolism"	""	0
"Benzo a pyrene metabolism"	-Inf	1	"Benzo a pyrene metabolism"	""	0
"Glucuronidation"	-Inf	1	"Glucuronidation"	""	0
"Aflatoxin B1 metabolism"	-Inf	1	"Aflatoxin B1 metabolism"	""	0
"Metapathway biotransformation Phase I and II"	-1.39368685339026	0.523612350929938	"Metapathway biotransformation Phase I and II"	"79829"	1
"Methylation pathways"	-Inf	1	"Methylation pathways"	""	0
"Sudden infant death syndrome SIDS susceptibility pathways"	-Inf	0.176192655263904	"Sudden infant death syndrome SIDS susceptibility pathways"	""	0
"DNA damage response"	-Inf	1	"DNA damage response"	""	0
"DNA damage response only ATM dependent "	-Inf	0.410209043527841	"DNA damage response only ATM dependent "	""	0
"Estrogen signaling pathway"	1.10107783835932	0.277338416506654	"Estrogen signaling pathway"	"3551"	1
"Vitamin A and carotenoid metabolism"	-Inf	1	"Vitamin A and carotenoid metabolism"	""	0
"Serotonin HTR1 group and FOS pathway"	-Inf	1	"Serotonin HTR1 group and FOS pathway"	""	0
"Monoamine transport"	-Inf	1	"Monoamine transport"	""	0
"Serotonin receptor 2 and ELK SRF GATA4 signaling"	-Inf	1	"Serotonin receptor 2 and ELK SRF GATA4 signaling"	""	0
"Serotonin receptor 4 6 7 and NR3C signaling"	-Inf	1	"Serotonin receptor 4 6 7 and NR3C signaling"	""	0
"Toll like receptor signaling pathway"	0.25065419440983	0.656586831119499	"Toll like receptor signaling pathway"	"5600;3551"	2
"TCA cycle aka Krebs or citric acid cycle "	-Inf	1	"TCA cycle aka Krebs or citric acid cycle "	""	0
"Nucleotide GPCRs"	-Inf	1	"Nucleotide GPCRs"	""	0
"Prostaglandin synthesis and regulation"	-Inf	1	"Prostaglandin synthesis and regulation"	""	0
